Page 1 Extracted Terms:
- Adult congenital heart disease  
- Aortic coarctation  
- Aortic valve stenosis  
- Cardiac catheterization  
- Cardiac surgical procedures  
- Cor triatriatum  
- Coronary vessel anomalies  
- Discrete subaortic stenosis  
- Ductus arteriosus (including patent ductus arteriosus)  
- Ebstein anomaly  
- Congenital heart defects  
- Heart septal defects (e.g., ventricular septal defect)  
- Pulmonary valve stenosis  
- Tetralogy of Fallot  
- Transposition of the great vessels  
- Ventricular outflow obstruction  
- Reoperation (post‑surgical)  
- Follow‑up studies / treatment outcomes  
- Survival rate / therapy outcomes

Page 2 Extracted Terms:
- Heart Failure  
- Heart Transplantation  
- Mechanical Circulatory Support (MCS)  
- Cyanosis  
- Shunt Lesions  
- Atrial Septal Defect (ASD)  
- Ventricular Septal Defect (VSD)  
- Atrioventricular Septal Defect (AVSD)  
- Anomalous Pulmonary Venous Connections  
- Patent Ductus Arteriosus (PDA)  
- Cor Triatriatum Sinister  
- Congenital Mitral Stenosis (including Shone Complex)  
- Subaortic Stenosis  
- Congenital Aortic Valve Diseases  
- Supravalvar Aortic Stenosis  
- Coarctation of the Aorta  
- Ebstein Anomaly  
- Valvular Pulmonary Stenosis  
- Double‑Chambered Right Ventricle (DCRV)  
- Isolated Branch Pulmonary Artery Stenosis  
- Tetralogy of Fallot  
- Pulmonary Atresia with Intact Ventricular Septum  
- Right Ventricle‑to‑Pulmonary Artery Conduits  
- Dextro‑Transposition of the Great Arteries (dTGA)  
- Congenitally Corrected Transposition of the Great Arteries (CCTGA)  
- Truncus Arteriosus  
- Double‑Outlet Right Ventricle (DORV)  
- Fontan Palliation of Single‑Ventricle Physiology  
- Eisenmenger Syndrome  
- Anomalous Aortic Origin of a Coronary Artery  
- Anomalous Coronary Artery Arising from the Pulmonary Artery  
- Coronary Artery Fistula  
- Vascular Rings  
- Pulmonary Artery Slings  
- Genetic Syndromes Screening (related to cardiac anomalies)  
- Reproductive Health, Pregnancy, and Contraception (cardiovascular considerations)

Page 3 Extracted Terms:
**Key Heart‑Disease–Related Terms Extracted from the Guideline**

- Adult Congenital Heart Disease (ACHD)  
- ACHD Program  
- ACHD Cardiologist  
- AP Classification (e.g., Class IA, IC–D, IIB–D, IIIA–D, IIC–D, IIA–D)  
- Non‑cardiac Surgery  
- Perioperative Complications  
- Guideline‑Based Medical Therapy (GDMT)  
- Invasive Cardiac Procedures  
- Risk Stratification  
- Periprocedural Planning  
- Post‑procedural Care  
- Anesthesia Collaboration with ACHD Expertise  
- Cardiac Surgery  
- Cyanosis Management  
- Heart Failure  
- Heart Transplantation  
- Mechanical Circulatory Support (MCS)  
- Genetic Syndromes Screening  
- Genetic Evaluation Referral  
- Reproductive Health (Pregnancy & Contraception)  
- Assisted Reproductive Technology  
- Routine Cesarean Delivery Policy  
- Physical Activity, Exercise, Sports Participation  
- Severe Pulmonary Hypertension  
- Eisenmenger Syndrome  
- Atrial Septal Defect (ASD)  
- Pulmonary Arterial Hypertension (PAH)  
- Pulmonary Hypertension Specialists  
- Left‑to‑Right Shunt (Qp:Qs)  
- Pulmonary Artery (PA) Systolic Pressure  
- Pulmonary Vascular Resistance (PVR)  
- Secundum ASD  
- Transcatheter Closure of ASD  
- Surgical Repair of ASD  
- Pulmonary Vascular Resistance Ratio (PVR to systemic resistance)  
- Pulmonary Artery Pressure ≥ 50 % of systemic  

*(Additional terms such as “net left‑to‑right shunt,” “≥ 1.5:1 Qp:Qs,” and “≥ 1/3 systemic resistance” are included within the list of measurement criteria above.)*

Page 4 Extracted Terms:
- Atrial Septal Defect (ASD)  
- Ventricular Septal Defect (VSD)  
- Atrioventricular Septal Defect (AVSD)  
- Anomalous Pulmonary Venous Connections (APVC)  
- Patent Ductus Arteriosus (PDA)  
- Cor Triatriatum Sinister  
- Pulmonary Arterial Hypertension (PAH)  
- Pulmonary Vascular Resistance (PVR)  
- Qp:Qs ratio (left‑to‑right shunt ratio)  
- Right Ventricular (RV) dilation  
- Right Ventricular Outflow Tract (RVOT) obstruction  
- Double‑Chambered Right Ventricle (DCRV)  
- Left Ventricular (LV) systolic dysfunction  
- Left Ventricular ejection fraction (EF) < 50%  
- Pulmonary hypertension (PH)  
- Pulmonary hypertension specialist  
- Heart failure (HF)  
- Functional status / functional class  
- Dyspnea on exertion  
- Cardiac imaging (echocardiography, MRI, CT angiography)  
- Surgical repair / closure  
- Gradient across obstruction (mm Hg)  
- Residual shunt  
- Net left‑to‑right shunt (Qp:Qs ≥ 1.5:1)  
- RV size and function assessment  
- Left atrial hypertension  
- Coronary artery disease (implicitly related)  
- Cardiac catheterization  
- CMR (cardiac magnetic resonance)  
- CT (computed tomography) angiography  
- Ventricular hypertrophy (RV or LV)  
- Hemodynamic measurements (systolic pressure, systemic pressure)  
- Perianeurysmal obstruction  
- Cardiopulmonary risk assessment  
- Surgical resection (membrane removal, valve repair)  
- Repaired vs unrepaired congenital defects  
- Ventricular function monitoring  
- Chronic embolism risk  
- Paradoxical embolism  

These terms encapsulate the key heart‑disease concepts discussed in the guideline excerpts.

Page 5 Extracted Terms:
- Cor Tiatriatum Sinister  
- Atrial Fibrillation  
- Atrial Flutter  
- Prior Stroke  
- Left Atrial Thrombus  
- Chronic Anticoagulation  
- Rhythm Control Strategy  
- Clinical Decompensation  
- Congenital Mitral Stenosis  
- Shone Complex  
- Pulmonary Hypertension  
- Bicuspid Aortic Valve  
- Aortic Diameter > 4 cm  
- Thoracic Aortic Disease  
- Aortic Dissection  
- Lifelong Surveillance  
- Valve Replacement (Surgical / Transcatheter)  
- Heart Valve and ACHD Expert Teams  
- Coarctation of the Aorta  
- Exertional Symptoms  
- Coronary Artery Disease Evaluation  
- Electrophysiological Study  
- Catheter Ablation  
- Ventricular Preexcitation  
- Supraventricular Tachycardia  
- Valvular Pulmonary Stenosis (Moderate/Severe)  
- Tricuspid Regurgitation  
- Right Ventricular Dysfunction  
- Pulmonary Valve Intervention  
- Isolated Pulmonary Regurgitation  
- Cardiovascular Magnetic Resonance (CMR) Imaging  
- Right Ventricular (RV) Volumes  
- RV Systolic Function  
- Cardiac Catheterization  
- Double‑Chambered Right Ventricle (DCRV)  
- RVOT Obstruction  
- Cardiac CT  
- Branch Pulmonary Artery Stenosis  
- Pulmonary Artery Dilation  
- Stenting  
- Balloon Angioplasty  
- Tetralogy of Fallot (TOF)  
- Echocardiography  
- Pulmonary Valve Dysfunction  
- Right Atrial Size  
- Ventricular Size  
- Residual Ventricular Septal Defects (VSDs)  
- RV Systolic Pressure  
- Right Ventricular Outflow Tract (RVOT)  
- Transcatheter Pulmonary Valve Replacement  
- Implantable Cardioverter‑Defibrillator (ICD)  
- Monomorphic Ventricular Tachycardia  
- Adjunctive Catheter Ablation  
- Pulmonary Valve Replacement (Surgical / Transcatheter)

Page 6 Extracted Terms:
**Key Terms Related to Heart Disease**

- **Right Ventricle‑to‑Pulmonary Artery (RV‑to‑PA) Conduit**  
- **Right Ventricle**  
- **Pulmonary Artery**  
- **Coronary CT**  
- **Conduit Calcification**  
- **Anatomic Characteristics**  
- **Coronary Artery Proximity**  
- **Transcatheter Intervention**  
- **Pulmonary Regurgitation (PR)**  
- **Stenosis**  
- **Functional Capacity**  
- **Arrhythmia**  
- **Severe Stenosis**  
- **Severe Regurgitation**  
- **Cardiovascular Status**  
- **Dextro‑Transposition of the Great Arteries (d‑TGA)**  
- **Atrial Switch**  
- **Progressive Exercise Intolerance**  
- **Heart Failure (HF)**  
- **Cardiopulmonary Exercise Testing**  
- **Interatrial Baffle**  
- **Venous Stenosis**  
- **Transvenous Pacemaker**  
- **Implantable Cardioverter‑Defibrillator (ICD)**  
- **Invasive Hemodynamic Assessment**  
- **Medical, Percutaneous, or Surgical Intervention**  
- **Baffle Stenosis**  
- **Residual Baffle Leaks**  
- **Biomarkers**  
- **Disease‑Specific Risk Scores**  
- **Cardiac Events**  
- **HF Transplant Centers**  
- **Ambulatory Monitoring**  
- **Bradycardia**  
- **Sinus Node Dysfunction**  
- **Beta Blockers**  
- **Rate‑Slow‑ing Agents**  
- **Resting Electrocardiogram (ECG)**  
- **Outpatient Ambulatory Rhythm Monitoring**  
- **Tachyarrhythmia**  
- **Baffle Leak**  
- **Baffle Leak Closure**  
- **Systemic or Pulmonary Venous Pathway Stenosis**  
- **Liver Congestion**  
- **Mechanical Support**  
- **Transplantation**  
- **ACHD Cardiologist**  
- **Guideline‑Directed Medical Therapy (GDMT)**  
- **Anticoagulation**  
- **Sinus Rhythm**  
- **Atrial Arrhythmia**  
- **Intra‑atrial Reentrant Arrhythmias**  
- **Atrial Fibrillation**  
- **Oral Anticoagulation**  
- **Embolic Events**  
- **Transvenous Lead Placement**  
- **Catheter‑Based Interventions**  
- **Systemic Thromboembolism**  
- **Future Baffle Occlusion**  
- **Physiological Tests of Myocardial Perfusion**  
- **Myocardial Ischemia**  
- **Coronary Angiography**  
- **Cross‑Sectional Imaging**  
- **Functional Coronary Assessment**  
- **Anatomic Etiology**

Page 7 Extracted Terms:
- Arterial Switch Operation  
- Myocardial ischemia  
- Coronary revascularization  
- Supravalvar PA stenosis  
- Branch PA stenosis  
- RV hypertension  
- RV dysfunction  
- Tricuspid regurgitation  
- Exercise capacity  
- d‑Transposition of the great arteries (d‑TGA)  
- Rastelli Repair  
- Congenitally corrected transposition of the great arteries (CCTGA)  
- Transthoracic echocardiography  
- Chamber function  
- Systemic tricuspid valve function  
- Septal defects  
- LVOT stenosis  
- Ambulatory rhythm monitoring  
- Atrioventricular block (high‑grade)  
- Physiologic pacing  
- Cardiac resynchronization therapy (CRT)  
- Conduction system pacing  
- Fontan circulation  
- Fontan circulatory failure  
- Heart failure (HF)  
- Transplant cardiology  
- Hepatocellular carcinoma  
- Fontan‑associated liver disease  
- Hepatic fibrosis / cirrhosis  
- Advanced cardiac imaging  
- Cardiovascular magnetic resonance (CMR)  
- Computed tomography (CT)  
- Transesophageal echocardiography  
- Thrombus  
- Emboli  
- Liver biopsy  
- Sinus node dysfunction  
- Atrial flutter  
- Atrial fibrillation  
- Cardioversion (pharmacologic or electrical)  
- Cardiac transplantation  
- Transplant‑free survival  
- Apical site pacing  
- Nonapical site pacing  
- Portal hypertension  
- CT angiography  
- Radiologic protocols (avoid false‑negative/false‑positive)

Page 8 Extracted Terms:
- Fontan circulation  
- Fontan palliation  
- Single‑ventricle physiology  
- Hemodynamically significant stenosis  
- Fontan pressure  
- Pulmonary arteries (PAs)  
- Systemic ventricular volume overload  
- Antiplatelet therapy  
- Anticoagulation  
- Vitamin K antagonist  
- Atrial flutter  
- Atrial fibrillation  
- Atriopulmonary Fontan  
- HLHS (Hypoplastic Left Heart Syndrome)  
- Norwood repair  
- Eisenmenger syndrome  
- Pregnancy (in Eisenmenger)  
- Bosentan  
- Phosphodiesterase‑type 5 inhibitors  
- Sildenafil  
- Tadalafil  
- PAH‑directed therapy  
- Endothelin receptor antagonist  
- Atrial arrhythmias  
- Sinus rhythm  
- Exercise program  
- Oral anticoagulation  
- Intracardiac shunt  
- Permanent pacing  
- Implantable cardioverter‑defibrillator (ICD)  
- Endocardial leads  
- Annual laboratory evaluation  
- Liver function testing  
- Renal function testing  
- Hematologic abnormality  
- Annual biochemical and hematological testing  
- Hemodynamics  
- Systemic thromboembolism

Page 9 Extracted Terms:
- Congenital heart disease (ACHD)  
- ACHD centers  
- ACHD cardiologist  
- Multidisciplinary team (complex‑care decision making)  
- Cardiac procedures  
- Non‑cardiac procedures  
- Endocarditis risk evaluation  
- Bioprosthetic pulmonary valves  
- Subacute bacterial endocarditis  
- Tetralogy of Fallot  
- Pulmonary valve replacement  
- Right ventricular end‑systolic volume (>80 mL/m²)  
- Right ventricular end‑diastolic volume (referenced)  
- Arrhythmia management  
- Ventricular tachycardia  
- Ablation therapy  
- Secundum atrial septal defect  
- Pulmonary arterial hypertension  
- Left‑to‑right shunt  
- Pulmonary vascular resistance (≤ 2 Wood units; 2–5 Wood units)  
- Atrial arrhythmias  
- Systemic right ventricle  
- Fontan circulation  
- Heart failure therapy (guideline‑directed medical therapy)  
- Systemic left ventricle  
- Pacing strategies (systemic right ventricle / Fontan)  
- Eisenmenger syndrome  
- Pulmonary vasodilators  
- Phosphodiesterase‑5 inhibitors  
- Endothelin receptor antagonists  
- Fontan‑screening for liver disease  
- Alpha‑fetoprotein  
- Hepatologist consultation  
- American College of Cardiology (ACC)  
- American Heart Association (AHA)  
- Anomalous aortic origin of a coronary artery (AAOCA)  
- Ventricular arrhythmias (AAOCA presentation)  
- High‑risk anatomy (AAOCA)  
- Vascular rings  
- Pulmonary artery slings  

*(Each item is a key term related to heart disease extracted from the guidelines text.)*

Page 10 Extracted Terms:
- Guideline‑directed medical therapy (GDMT)  
- Adults with congenital heart disease (ACHD)  
- Cardiovascular disease  
- Cardiac imaging  
- Percutaneous coronary intervention  
- Coronary artery bypass grafting  
- Heart failure management  
- Arrhythmia treatment  
- Device therapy (e.g., pacemaker, implantable cardioverter‑defibrillator)  
- Pharmacologic therapy (beta‑blockers, ACE inhibitors, ARBs, diuretics, anticoagulants)  
- Clinical evaluation of cardiac symptoms  
- Diagnostic testing for heart disease  
- Shared decision‑making in cardiac care  
- Patient engagement in cardiac treatment planning  
- Comorbidities influencing cardiac outcomes  
- Randomized controlled trials (RCTs) in cardiology  
- Systematic reviews of cardiac interventions  
- Evidence‑based guideline recommendations for heart disease  
- ACC/AHA Joint Committee on Clinical Practice Guidelines  
- National Academy of Medicine (formerly Institute of Medicine) – cardiology standards  
- Cost‑value analysis of cardiac drugs and devices  
- Knowledge‑chunk format for cardiovascular guideline presentation  
- Flow diagrams for cardiac decision pathways  
- Contraindications and drug–drug interactions in cardiac therapy  
- Regulatory approval of cardiac drugs and devices in the United States.

Page 11 Extracted Terms:
- Adult congenital heart disease  
- Aortic coarctation  
- Aortic valve stenosis  
- Cardiac catheterization  
- Cardiac surgical procedures  
- Congenital heart disease  
- Cor triatriatum  
- Coronary vessel anomalies  
- Diagnostic imaging  
- Discrete subaortic stenosis  
- Patent ductus arteriosus  
- Ebstein anomaly  
- Congenital heart defects  
- Ventricular septal defects  
- Pulmonary valve stenosis  
- Reoperation  
- Surgery  
- Survival rate  
- Tetralogy of Fallot  
- Therapy  
- Transposition of the great vessels  
- Treatment outcome  
- Ventricular outflow obstruction  
- Valvular heart disease  
- Bicuspid aortic valve disease  
- Aortopathy associated with bicuspid aortic valve  
- Conotruncal abnormalities  
- Heart failure  
- Cardiovascular diseases  
- Aortic disease  
- Inherited connective‑tissue disorders with cardiac manifestations (e.g., Marfan syndrome, hypertrophic cardiomyopathy)  
- Patent foramen ovale  
- Anatomic variants of the heart  
- Congenital valve disease (distinct from acquired valvular disease)

Page 12 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Coronary artery disease  
- Heart failure  
- Arrhythmias  
- Valvular heart disease  
- Chest pain  
- Coronary artery revascularization  
- Aortic disease  
- Chronic coronary disease  
- Atrial fibrillation  
- Genetic basis for congenital heart disease  
- Multimodality imaging during follow‑up care of congenital heart disease  
- Transition to adulthood for adolescents with congenital heart disease  
- Repaired tetralogy of Fallot (arrhythmias)  
- Dual‑organ transplantation (heart‑kidney, heart‑liver)  
- Neurodevelopmental outcomes for individuals with congenital heart disease  
- Psychological outcomes and interventions for congenital heart disease  

*(These terms represent the major cardiac conditions, procedures, and related concepts referenced in the guideline.)*

Page 13 Extracted Terms:
- American College of Cardiology  
- American Heart Association  
- ACHD Guideline (Acute Congenital Heart Disease)  
- Clinical strategies  
- Interventions  
- Treatments  
- Diagnostic testing

Page 14 Extracted Terms:
- ACHD (adult congenital heart disease)  
- congenital heart disease  
- anatomic lesions  
- anatomical repairs  
- International Paediatric and Congenital Cardiac Code  
- anatomic complexity (simple–complex I–III)  
- physiological stage (A–D)  
- residual anatomic sequelae  
- advanced heart failure  
- pulmonary arterial hypertension (PAH)  
- valve replacement  
- arrhythmias  
- Fontan circulation  
- systemic right ventricle  
- truncus arteriosus  
- coarctation of the aorta (COA)  
- ventricular dysfunction  
- mortality risk  
- surgical outcomes  
- maternal and fetal complications of pregnancy  
- risk‑stratification tools  
- non‑cardiac procedures at ACHD centers  
- invasive cardiac procedures  
- cardiac anesthesia  
- reproductive health, pregnancy, and delivery  
- hemodynamic stress  
- ACHD consultation  
- routine diagnostic studies  
- follow‑up intervals  
- biomarkers (e.g., N‑terminal pro‑hormone of B‑type natriuretic peptide, NT‑proBNP)  
- unplanned heart‑failure hospitalizations  
- endocarditis.

Page 15 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Acquired heart disease  
- Atrial septal defect (ASD)  
- Patent ductus arteriosus (PDA)  
- Ventricular septal defect (VSD)  
- Pulmonic stenosis  
- Anomalous aortic origin of a coronary artery from the opposite sinus  
- Anomalous coronary artery arising from the pulmonary artery  
- Anomalous pulmonary venous connection (partial or total)  
- Atrioventricular septal defect (partial or complete)  
- Congenital aortic valve disease  
- Congenital mitral valve disease  
- Coarctation of the aorta  
- Cor triatriatum sinister  
- Dextro‑transposition of the great arteries (TGA) after arterial switch operation  
- Ebstein anomaly  
- Infundibular right ventricular outflow obstruction / double‑chamber right ventricle  
- Peripheral pulmonary artery stenosis  
- Sinus venosus defect  
- Subvalvular aortic stenosis  
- Supravalvar aortic stenosis  
- Tetralogy of Fallot  
- Vascular ring or sling  
- Double‑outlet ventricle  
- Fontan physiology  
- Interrupted aortic arch  
- Pulmonary atresia (all forms)  
- Single‑ventricle anatomy (including double‑inlet left ventricle, tricuspid/mitral atresia, hypoplastic left heart)  
- Congenitally corrected TGA (CCTGA, levo‑TGA)  
- Dextro‑TGA after atrial switch (Mustard/Senning) operation  
- Dextro‑TGA after Rastelli operation  
- Truncus arteriosus  
- Unrepaired or partially palliated cyanotic congenital heart defect  
- Heart failure  
- B‑type natriuretic peptide (BNP)  
- N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP)  
- New York Heart Association (NYHA) functional class  
- Endocarditis  
- Eisenmenger syndrome  
- Pulmonary arterial hypertension (low‑risk, intermediate‑risk, high‑risk)  
- Arrhythmia (including sustained or high‑burden tachyarrhythmia)  
- Tachyarrhythmia  
- Implantable cardioverter‑defibrillator (ICD)  
- Permanent pacemaker  
- Hypoxemia (mild, moderate, severe)  
- Valve dysfunction (mild, moderate, severe)  
- Ventricular dysfunction (mild, moderate, severe)  
- Ventricular enlargement (mild)  
- Shunt (trivial/small, hemodynamically significant)  
- Hemodynamic sequelae  
- Hemodynamic significance  
- Physiological stage (A, B, C, D) in ACHD classification.

Page 16 Extracted Terms:
- AAOCA (anomalous aortic origin of a coronary artery)  
- ACHD (adult congenital heart disease)  
- AP (anatomic and physiological)  
- APVC (anomalous pulmonary venous connection)  
- ASD (atrial septal defect)  
- AVSD (atrioventricular septal defect)  
- BAV (bicuspid aortic valve)  
- BNP (B‑type natriuretic peptide)  
- CCTGA (congenitally corrected transposition of the great arteries)  
- CMR (cardiovascular magnetic resonance)  
- COA (coarctation of the aorta)  
- CPET (cardiopulmonary exercise testing)  
- CRT (cardiac resynchronization therapy)  
- CT (computed tomography)  
- DCRV (double‑chambered right ventricle)  
- d‑TGA (dextro‑transposition of the great arteries)  
- FALD (Fontan‑associated liver disease)  
- GDMT (guideline‑directed medical therapy)  
- HLHS (hypoplastic left heart syndrome)  
- ICD (implantable cardioverter‑defibrillator)  
- NYHA (New York Heart Association functional classification)  
- Qp:Qs (pulmonary‑to‑systemic blood flow ratio)  
- Arrhythmia (atrial or ventricular tachyarrhythmias)  
- Valvular heart disease (VHD) – mild, moderate, severe  
- Exercise capacity – objective and subjective limits  
- Hypoxemia (resting SpO₂ ≤ 92 %)  
- Severe hypoxemia (SpO₂ ≤ 85 %)  
- Hypoxia (tissue oxygenation inadequate)  
- Cyanosis (blue/purple discoloration, ≥ 5 g/dL desaturated Hb)  
- Pulmonary arterial hypertension (mean PA pressure ≥ 20 mm Hg, PAWP ≤ 15 mm Hg, PVR ≥ 2 WU)  
- Pulmonary arterial hypertension risk categories (3‑strata)  
- Hemodynamically significant intrathoracic shunt (Qp:Qs ≥ 1.5, chamber enlargement)  
- Ventricular dysfunction  
- Hemodynamics  
- Right heart catheterization  
- Hemodinamically significant intracardiac shunt  
- Cardiac resynchronization therapy (CRT)  
- Implanted defibrillator (ICD)  

These terms capture the key clinical concepts related to heart disease as presented in the guideline text.

Page 17 Extracted Terms:
- Acute congenital heart disease (ACHD)  
- Adult congenital heart disease (ACHD)  
- Left ventricular (LV)  
- Left ventricular outflow tract (LVOT)  
- Mechanical circulatory support (MCS)  
- Magnetic resonance (MR)  
- N-terminal pro‑brain natriuretic peptide (NT‑proBNP)  
- Pulmonary artery (PA)  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary atresia with intact ventricular septum (PA‑IVS)  
- Patent ductus arteriosus (PDA)  
- Pulmonary vascular resistance (PVR)  
- Pulmonary‑to‑systemic blood flow ratio (Qp:Qs)  
- Right ventricular (RV)  
- Right ventricular end‑diastolic volume (RVEDV)  
- Right ventricular outflow tract (RVOT)  
- Right ventricle‑to‑pulmonary artery (RV‑to‑PA)  
- Sudden cardiac death (SCD)  
- Sinus venosus atrial septal defect (SVASD)  
- Tetralogy of Fallot (TOF)  
- Ventricular septal defect (VSD)  
- Transition education  
- Transfer of care policies and procedures  
- Loss to care (attrition)  
- Transition education policies  
- Transition education procedures  
- Transfer-of-care protocols  
- Comprehensive transfer of care  
- Structured transition education  
- Patient‑centered transition education  
- Transition education success metrics  

Page 18 Extracted Terms:
**Key terms related to heart disease in the guideline**

- Adult Congenital Heart Disease (ACHD)  
- Congenital Heart Disease (CHD)  
- Transfer of care from pediatric to ACHD providers  
- Lifelong continuum of congenital heart disease care  
- Gaps in care delivery  
- Morbidity  
- Premature mortality  
- Electronic medical records (EMR)  
- Nurse navigator  
- Social worker  
- Insurance barriers  
- Distance to clinic  
- Work and career disruptions  
- Critical care stages: diagnosis, palliative interventions, transfer to ACHD, lifelong ACHD care, reinterventions  
- Continuous patient education  
- Congenital heart disease diagnosis specifics (name, anatomy, physiology)  
- Surgical procedures for CHD  
- Diagnostic evaluation  
- Reproductive health education  
- Development of independent skills (appointments, prescriptions, provider contact, insurance maintenance)  
- Lifelong specialized CHD care by ACHD cardiologists  
- Seamless transitions from pediatric to ACHD  
- Socioeconomic stress (risk factor for loss to care)  
- Ethnic disparities (non‑White patients)  
- Readiness for transfer of care  
- Referral policies to ACHD care  
- Tracking of transfer patients (via EMR and databases)  
- Early childhood (0‑12 years) CHD care  
- Adolescence to young adulthood (13‑18 years) CHD care  
- Young adulthood (18‑26 years) CHD care  
- Adulthood (18‑80+ years) CHD care  
- ACHD cardiologists and programs  
- Adult care hospitals  
- ACHD advocacy organizations  
- Telehealth as a care option  
- Advanced practice providers (e.g., nurse practitioners, physician assistants)  
- General cardiologists (for local care)  
- Geographic availability of ACHD cardiologists  
- Loss to care  
- Barriers to care (insurance, distance, socioeconomic factors)  
- Electronic health records and databases for monitoring care continuity  
- Policies and procedures for transfer, referral, and tracking of patients  
- Pediatric cardiology/heart centers  
- Payors (insurance carriers)  
- Congenital heart disease advocacy organizations 

Page 19 Extracted Terms:
**Key heart‑disease terms extracted from the text**

- Adult Congenital Heart Disease (ACHD)  
- ACHD clinical class (AP class)  
- Cardiologist / ACHD cardiologist  
- ACHD program / multidisciplinary ACHD program  
- Complex congenital anatomy and physiology  
- Cardiac interventions & surgical repairs  
- Long‑term complications of congenital heart disease  
- Diagnostic testing & follow‑up  

**Clinical and procedural domains**

- Advanced imaging  
  - Cardiac computed tomography (CT)  
  - Cardiovascular magnetic resonance (CMR)  
  - Echocardiography  
- Heart failure management  
- Heart or multiorgan transplant evaluation & listing  
- Diagnostic and interventional heart catheterization  
- Electrophysiology (arrhythmia, device implantation, EP study)  
- Cardiac surgery / cardiothoracic surgery  
- Cardiac anesthesia & ICU support  

**Specialist and support services**

- Congenital cardiac surgeon  
- Advanced practice provider  
- Registered nurse  
- Cardiac intensivist  
- Advanced heart‑failure and transplant cardiologist  
- Cardiac catheterization interventionalist  
- Electrophysiologist  
- Cardiac anesthesiologist  
- Maternal‑fetal medicine specialist  
- Hepatologist  
- Pulmonary hypertension specialist  
- Cardiovascular genetics specialist  
- Palliative medicine specialist  
- Social worker  
- Psychologist  

**Systemic/organizational factors**

- Barriers to care (geographic distance, insurance coverage, socioeconomic challenges)  
- Clinical evaluation for worsening AP class  
- Referral for advanced imaging beyond local expertise  
- Referral for worsening heart failure  
- Referral for transplant evaluation  
- Referral for diagnostic/interventional therapies  
- Referral for electrophysiology studies  
- Referral for cardiothoracic surgery  
- Pregnancy risk assessment/management  
- Non‑cardiac surgery in high‑risk populations (AP classes IC–D, IIA–D, IIIA–D)  
- Need for ACHD cardiac anesthesia and ICU support  

**Administrative and accreditation terms**

- Board certification (American Board of Internal Medicine, American Board of Pediatrics)  
- Accreditation Council for Graduate Medical Education (ACGME) training programs  
- High‑quality integrated multidisciplinary care  
- Evidence Table / guideline recommendations  

These terms capture the central concepts and entities related to heart disease management as presented in the clinical statements and guidelines excerpt.

Page 20 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Congenital heart disease  
- Complex congenital heart disease  
- Heart failure  
- Arrhythmias (including bradyarrhythmias)  
- Cyanosis  
- Pulmonary hypertension / Pulmonary vascular disease  
- Valvular disease  
- Ventricular function (systemic and subpulmonary)  
- Persistent shunts (right‑to‑left shunts)  
- Endocarditis prophylaxis  
- Erythrocytosis  
- Frailty  
- Perioperative complications (in the context of heart disease)  
- Pre‑operative optimization for cardiac risk  
- Risk stratification for cardiac patients  
- Periprocedural planning in cardiac patients  
- Management of anticoagulation in cardiac patients  
- Management of venous/arterial access in cardiac patients  

(These terms capture the key heart‑disease concepts addressed in the excerpt.)

Page 21 Extracted Terms:
**Key heart‑disease terms extracted from the text**

- Adult Congenital Heart Disease (ACHD)  
- Single‑ventricle physiology  
- Residual lesions / residual disease  
- Pre‑operative evaluation  
- Vascular resistances  
- Cyanosis  
- ACHD anatomic classification II/III  
- ACHD physiological stages C/D  
- ACHD program / specialized center  
- Systemic and pulmonary shunts  
- Post‑operative complications  
- Fluid shifts  
- Blood‑pressure variation  
- Oxygenation / ventilation parameters  
- Arrhythmias  
- Fontan physiology  
- Pulmonary vascular disease  
- Transpulmonary gradient  
- Systemic ventricular preload  
- Anesthetic planning for ACHD  
- Preload / afterload management  
- Vasoactive medications  
- Ventilator strategies  
- Pulmonary vascular resistance (PVR)  
- Hemodynamic monitoring  
- Coagulopathy risk  
- Paradoxical embolism (right‑to‑left shunts)  
- Ventricular septal defect (VSD)  
- Eisenmenger syndrome  
- Heart failure  
- Adverse cardiovascular outcomes  
- Health‑care utilization in ACHD patients  
- Neurocognitive and mental‑health considerations in ACHD (depression, anxiety, PTSD, cognitive decline, frailty)

Page 22 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Congenital heart disease (CHD)  
- ACHD cardiologist  
- Cardiology (congenital)  
- Cardiac surgery  
- Cardiac catheter‑based procedures  
- Electrophysiology (EP) procedures  
- Invasive cardiac procedures  
- Cardiac anesthesia  
- Perioperative complications  
- Risk stratification  
- Preprocedural evaluation  
- Postprocedural care  
- Guideline‑based therapy  
- Clinical outcomes  
- Periprocedural planning  
- Procedural optimization  
- High‑risk cardiac surgery  
- Device implantation (cardiac/EP)  
- Anesthesiologist with CHD expertise  
- Acquired cardiovascular disease in ACHD patients  
- Multidisciplinary collaboration (ACHD, anesthesiology, surgery, EP)

Page 23 Extracted Terms:
- Adult congenital heart disease (ACHD)  
- Atrioventricular (AV) complex pathology  
- Ablation protocol (AP) complexity  
- Palliated single ventricle physiology  
- Cyanosis  
- Valve disease  
- Heart failure  
- Arrhythmias  
- Invasive cardiac procedures  
- Periprocedural care  
- Procedural risk‑scoring systems  
- Coronary artery disease (CAD)  
- Aortic aneurysm  
- Calcific valvar stenosis  
- Iron deficiency anemia in ACHD  
- Hyperviscosity syndrome  
- Cerebral abscess  
- Stroke  
- Neurologic deficits  
- Anesthesia management in ACHD  
- Ventilation strategies in ACHD surgery  
- Cardio‑obstetrics care  
- Pregnancy‑related cardiovascular complications  
- Family planning in ACHD patients  
- Congenital heart surgery fellowship  
- ACHD cardiology board certification  
- Electrophysiology in ACHD  
- Interventional cardiology in ACHD  
- Multidisciplinary ACHD team  
- Ancillary imaging for ACHD  
- Surgical palliation sequelae  
- Hemodynamics of congenital lesions  
- Anesthetic pharmacology in ACHD  
- Co‑surgeon model (ACHD + acquired disease)

Page 24 Extracted Terms:
- Atrial‑ventricular congenital heart disease (ACHD)  
- Cyanotic heart disease  
- Cyanosis  
- Hypoxemia  
- Right‑to‑left shunt  
- Secondary erythrocytosis  
- Hyperviscosity syndrome  
- Hematocrit >65 %  
- Iron‑deficiency anemia  
- Pheochromocytoma  
- Paraganglioma  
- Eisenmenger syndrome  
- Stroke (ischemic)  
- Transient ischemic attack (TIA)  
- Pulmonary embolism  
- Thrombosis  
- Coagulation cascade  
- Hypercoagulability  
- Hypocoagulability  
- Hemoptysis  
- Epistaxis  
- Exercise intolerance  
- Myocardial ischemia  
- Neurologic complications (brain abscess, stroke)  
- Pregnancy‑related cardiovascular complications  
- Estrogen‑containing oral contraceptives (thromboembolic risk)  
- Anticoagulation and antiplatelet therapy  
- International normalized ratio (INR)  
- Hyperviscosity symptoms (headache, visual disturbance)  
- Hyperviscosity management (rehydration, iron replacement, phlebotomy)  

These terms capture the primary heart‑disease–related concepts discussed in the guideline excerpt.

Page 25 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Cyanosis (cyanotic ACHD)  
- Tachycardia  
- Hypertension  
- Pheochromocytoma  
- Paraganglioma  
- Plasma fractionated metanephrines  
- 24‑hour urinary fractionated metanephrines  
- Hyperuricemia  
- Gout  
- Reduced exercise capacity (in ACHD patients)  
- Supplemental oxygen use during exercise  
- Hyperviscosity symptoms  
- Iron deficiency (annual screening)  
- Hematocrit (HCT)

Page 26 Extracted Terms:
- ACHD (Aneuploidy or Congenital Heart Disease)  
- Acute phlebotomy (removal of 250–500 mL blood)  
- Hyperviscosity syndrome  
- Cyanosis  
- Iron deficiency  
- Stroke risk  
- Systemic left ventricular (LV) dysfunction  
- Biventricular circulation  
- Cardiac resynchronization therapy (CRT)  
- Guideline‑directed medical therapy (GDMT) for heart failure  
- Implantable cardioverter‑defibrillator (ICD)  
- Sudden cardiac death (SCD)  
- Mechanical circulatory support  
- Heart transplantation  
- Fontan physiology (single‑ventricle)  
- Systemic right ventricle (dextro‑TGA with atrial switch, CCTGA)  
- Endocarditis  
- Bradyarrhythmia  
- Restrictive physiology  
- Multimorbidity  
- Frailty  
- Polypharmacy  
- Ventricular activation pattern  
- Myocardial contraction  
- Electrical dyssynchrony  
- Cardiac remodeling  
- Overall survival  
- Quality of life  
- Heart failure hospitalization  
- Hematocrit level  
- Isotonic fluid replacement.

Page 27 Extracted Terms:
**Key terms related to heart disease extracted from the text**

- Acquired congenital heart disease (ACHD)  
- Systemic left ventricle (LV)  
- LV systolic dysfunction / severe LV dysfunction (ejection fraction ≤ 35%)  
- Global Guideline‑Directed Medical Therapy (GDMT)  
- Angiotensin Receptor–Neprilysin Inhibitors (ARNI)  
- Sodium‑Glucose Cotransporter 2 Inhibitors (SGLT2i)  
- Heart failure (HF) symptoms  
- Heart failure hospitalization  
- New York Heart Association (NYHA) functional class (II–III)  
- Biomarkers of cardiac strain  
- Sudden Cardiac Death (SCD)  
- SCD risk calculator (e.g., from CONCOR registry)  
- Ebstein anomaly  
- Post‑operative Fontan physiology  
- Systemic right ventricle  
- Implantable Cardioverter‑Defibrillator (ICD)  
- Primary‑prevention ICD placement  
- Inappropriate ICD shocks (e.g., in Tetralogy of Fallot)  
- Heart transplantation (HTx)  
- Mechanical Circulatory Support (MCS)  
- Temporary MCS (e.g., implantable vascular devices)  
- Durable MCS (LV or biventricular support)  
- Bridge to transplantation  
- Destination therapy  
- Multiorgan transplantation (heart‑lung, heart‑kidney, heart‑liver)  
- Fontan‑related transplantation indications  
- Transplant wait‑list management  
- High‑volume transplant centers with ACHD accreditation  
- Cardiogenic shock  

These terms capture the clinical entities, therapies, devices, and patient populations discussed in the guidelines.

Page 28 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Ventricular dysfunction  
- Systemic ventricular dysfunction  
- Heart failure  
- Advanced heart failure  
- Heart‑failure‑related hospital admissions  
- Cardiopulmonary exercise stress testing (CPET)  
- Heart transplantation  
- Heart‑lung transplantation  
- Heart‑kidney transplantation  
- Heart‑liver transplantation  
- Multiorgan transplantation  
- Eisenmenger syndrome  
- Fontan palliation  
- Fontan physiology  
- Durable mechanical circulatory support (MCS)  
- Temporary mechanical circulatory support  
- Mechanical circulatory support (MCS)  
- Advanced liver fibrosis  
- Conotruncal defects  
- Heterotaxy  
- 22q11.2 deletion syndrome  
- Congenital heart disease  
- Genetic syndromes screening  

Page 29 Extracted Terms:
- Conotruncal anomalies  
- Infundibulum (outflow tract)  
- Great arteries  
- 22q11.2 deletion syndrome (DiGeorge syndrome, velocardiofacial syndrome)  
- Tetralogy of Fallot  
- Ventricular septal defect (VSD)  
- Pulmonary atresia  
- Interrupted aortic arch type B  
- Truncus arteriosus  
- Down syndrome (trisomy 21)  
- Atrial septal defect (ASD)  
- Atrioventricular septal defect (AVSD)  
- Holt‑Oram syndrome (TBX5)  
- Klinefelter syndrome (47,XXY) – patent ductus arteriosus, ASD, mitral valve prolapse  
- Noonan syndrome (PTPN11, KRAS, SOS1, RAF1, NRAS, BRAF, MAP2K1) – pulmonary stenosis, ASD, hypertrophic cardiomyopathy, AVSD  
- Turner syndrome (45,X) – bicuspid aortic valve, coarctation of the aorta, aortopathies, partial anomalous pulmonary venous connection, atherosclerosis risk  
- Williams syndrome (7q11.23 deletion) – supravalvar aortic stenosis, branch pulmonary artery stenosis, supravalvar pulmonary stenosis, coronary ostial stenosis, QTc prolongation, mid‑aortic narrowing syndrome  
- Alagille syndrome (JAG1) – peripheral or branch pulmonary artery stenosis, coarctation of the aorta, aortic stenosis, septal defects, mid‑aortic narrowing  
- Heterotaxy syndrome  
  - ZIC3, SHROOM3, GRK5, ANKS3, NODAL, CFC1, LEFTY2, GDF1, SMAD2, ACVR2B  
  - Situs abnormalities, ciliary dysfunction, functional asplenia, conduction abnormalities, biliary atresia, atrioventricular septal defects (balanced/unbalanced), malposed great vessels, interrupted IVC, bilateral SVC, atrial isomerism  
- Bicuspid aortic valve  
- Coarctation of the aorta  
- Aortic arch abnormalities  
- Pulmonary stenosis  
- Left‑ventricular hypertrophy / hypertrophic cardiomyopathy  
- Coronary ostial stenosis  
- QTc prolongation  
- Atherosclerosis risk (associated with Turner syndrome)  
- Partial anomalous pulmonary venous connection  
- Aortic stenosis  
- Valvular disease (mitral valve prolapse, pulmonary stenosis)  
- Conduction abnormalities (associated with various syndromes)

Page 30 Extracted Terms:
**Key terms related to heart disease extracted from the text**

1. Congenital heart disease  
2. ACHD (Adult Congenital Heart Disease)  
3. Genetic referral / genetic evaluation  
4. Genetic counseling / preconception genetic counseling  
5. Noonan syndrome  
6. Williams syndrome  
7. Heterotaxy syndrome  
8. QTc prolongation  
9. Sudden cardiac death  
10. Cardiac monitoring  
11. Cardiologist (ACHD cardiologist)  
12. Cardio‑obstetrics team  
13. Peripartum cardiomyopathy  
14. Spontaneous coronary artery dissection  
15. Mechanical heart valves (mechanical valvular prostheses)  
16. Arrhythmia  
17. Heart failure  
18. Thromboembolic events / thrombosis  
19. Estrogen‑containing contraceptive agents  
20. Maternal morbidity and mortality  
21. Pregnancy‑related cardiac complications  
22. Pre‑risk stratification / risk scores for cardiac patients in pregnancy  
23. Maternal cardiac risk management  
24. Obstetric cardiac surveillance (cardiac monitoring during pregnancy)  
25. Cesarean delivery (in the context of cardiac risk)  
26. Assisted reproductive technology (ART) and cardiac risk  
27. Cardiac procedural outcomes / surgical outcomes  
28. Platelet dysfunction (in the context of Noonan syndrome)  
29. Anesthesia‑related cardiac risk (QTc prolongation risk)  
30. Cardiac risk stratification in pregnancy (AP classifications IB–D, IIA–D, IIIA–D)  

These terms capture the primary heart‑disease concepts, syndromic associations, reproductive‑cardiac considerations, and procedural/therapeutic elements highlighted in the clinical statements and guidelines.

Page 31 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Cardio‑obstetrics team  
- Hemodynamic effects of pregnancy  
- Contraceptive agents (in ACHD)  
- Modified World Health Organization (WHO) classification system  
- CARPREG 2 score  
- Maternal cardiac risk  
- Fetal echocardiography  
- Pulmonary arterial hypertension (PAH)  
- Eisenmenger syndrome  
- Severe ventricular dysfunction  
- Left‑sided obstructive lesions (e.g., mitral and aortic stenosis)  
- Systemic right ventricle with depressed function  
- New York Heart Association (NYHA) functional class III/IV  
- Aortopathy (≥ 5 cm diameter or connective‑tissue disorder)  
- Mechanical heart valves  
- Refractory ventricular arrhythmias  
- Fontan physiology  
- Severe native coarctation or recoarctation  
- Cyanotic congenital heart disease  
- Advanced NYHA class (III or IV)  
- Systemic ventricular dysfunction (EF < 30 %)  



Page 32 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Pulmonary Arterial Hypertension (PAH)  
- Fontan physiology  
- Mechanical heart valves  
- Thrombotic events / thromboembolism  
- Anticoagulation therapy  
- Estrogen‑containing contraceptive agents (contraindicated in ACHD)  
- High‑risk aortopathies (high‑risk cardiac conditions)  
- Ionizing radiation exposure  
- Cardiac catheterization  
- Invasive electrophysiology procedures  
- Computed tomography (CT) scans  
- Nuclear perfusion scans  
- Chest X‑rays  
- Cardiopulmonary exercise testing (CPET)  
- Six‑minute walk test  
- New York Heart Association (NYHA) functional class  
- Cardiovascular procedures (general)  
- Radiation dose‑reduction strategies (low‑dose ionizing radiation)  
- Cancer risk associated with cardiac imaging  
- Functional capacity assessment (exercise capacity, symptom severity)  
- Adverse cardiovascular events (hospitalization, mortality)  
- Maternal cardiac outcomes (in pregnancy)  

These terms capture the key concepts and clinical focus areas related to heart disease within the provided guideline text.

Page 33 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Cardiopulmonary Exercise Testing (CPET)  
- Six‑Minute Walk Test  
- Pulmonary Arterial Hypertension (PAH)  
- Heart Failure  
- Mortality  
- Major Adverse Cardiovascular Events  
- Hemodynamic Intervention  
- Surgical Reintervention  
- Functional Capacity  
- Exercise Capacity  
- Physical Activity  
- Sports Participation  
- Cardiac Rehabilitation  
- Systemic Ventricular Systolic Dysfunction  
- Systemic Ventricular Outflow Tract Obstruction  
- Hemodynamically Significant Arrhythmias  
- Aortic Dilation  
- Tetralogy of Fallot (TOF)  
- Systemic Right Ventricle  
- Fontan Palliation  
- Unrepaired Cyanotic Heart Disease  
- Metabolic Equivalents (METs)  
- Predicted Maximum Heart Rate  
- NT‑proBNP  
- Fibrinogen  
- Cardiac Autonomic Function  
- Vascular Function  
- Quality of Life  
- Self‑Reported Health Status  
- Borg Scale (breathlessness rating)  
- Intensity Rating of Breathlessness  
- Exercise Training  
- Cardiac Rehab Program  
- Cardiovascular Events

Page 34 Extracted Terms:
- Adult congenital heart disease (ACHD)  
- Congenital shunt lesions  
- Atrial septal defect (ASD)  
- Ventricular septal defect (VSD)  
- Atrio‑ventricular septal defect (AVSD)  
- Patent ductus arteriosus (PDA)  
- Anomalous pulmonary venous return  
- Left‑to‑right shunt  
- Right‑to‑left shunt  
- Shunt magnitude / size  
- Pulmonary‑to‑systemic blood flow ratio (Qp:Qs) ≥ 1.5  
- Eisenmenger syndrome  
- Pulmonary arterial hypertension (PAH)  
- Mean pulmonary artery pressure > 20 mm Hg  
- Pulmonary vascular resistance (PVR) > 2 Wood units  
- Pulmonary arterial wedge pressure ≤ 15 mm Hg  
- Resting hypoxemia / cyanosis  
- Risk assessment tools (e.g., 3‑strata, 4‑strata models)  
- 6‑minute walk distance (6MWD)  
- B‑type natriuretic peptide (BNP)  
- C‑reactive protein  
- Echocardiography  
- Exercise‑induced hypoxemia  
- Formal exercise testing  
- Rhythm monitoring  
- Imaging studies  
- Multidisciplinary care strategy  
- Shared decision‑making  
- Exercise testing for competitive sports  
- PH‑specific therapies  
- Endothelin‑receptor antagonists  
- Phosphodiesterase‑5 inhibitors  
- Prostacyclin analogs  
- Oral prostacyclin receptor analogs  
- Activin‑signaling inhibitors  
- Perioperative risk  
- Cardiovascular morbidity & mortality  
- Competing health outcomes (e.g., exercise capacity vs. PAH progression)

Page 35 Extracted Terms:
- Atrial Septal Defect (ASD)  
- Unrepaired ASD  
- ASD closure  
- Percutaneous closure  
- Surgical closure  
- Transcatheter closure  
- Fenestrated closure (fenestrated repair)  
- Partial defect closure (fenestrated closure)  
- Closure contraindicated (high‑risk closure)  
- Pulmonary Arterial Hypertension (PAH)  
- Pulmonary vascular resistance (PVR)  
- Wood units (unit of PVR measurement)  
- Left‑to‑right shunt (Qp:Qs ratio)  
- Qp:Qs ≥ 1.5  
- RV dilation (right‑ventricular dilation)  
- LV disease (left‑ventricular disease)  
- Significant LV disease (chronically elevated left‑atrial pressure ≥ 15 mm Hg)  
- Eisenmenger physiology  
- Transesophageal echocardiography (TEE)  
- Cardiac magnetic resonance imaging (CMR)  
- Cardiac computed tomography (CT)  
- Pulmonary venous connections  
- Anomalous pulmonary venous return  
- Paradoxical embolism  
- Paradoxical embolism prevention (ASD closure)  
- Right‑to‑left shunting  
- Right‑heart chamber enlargement  
- Right‑ventricular dysfunction  
- Functional class (NYHA/WHO)  
- Clinical outcomes  
- Medium‑term functional status  
- Targeted PAH therapy  
- Risk assessment and management (pulmonary hypertension specialists)  
- Post‑closure hemodynamic assessment  
- Long‑term PAH therapies  
- Treat‑and‑repair approach (treat‑and‑repair)  
- Pre‑tricuspid shunts  
- Shunt type: secundum, primum, sinus venosus (superior/inferior), unroofed coronary sinus  
- Hemodynamic consequences of ASD  
- Atrial arrhythmia (post‑closure arrhythmias)  
- High pressure (right‑sided or left‑sided)  
- Diagnostic imaging: transthoracic echocardiography (TTE)  
- Cross‑sectional imaging (for distant pulmonary venous connections)  

*(All terms extracted from the provided clinical guideline text.)*

Page 36 Extracted Terms:
- Atrial Septal Defect (ASD)  
- Adult Congenital Heart Disease (ACHD)  
- Pulmonary Arterial Hypertension (PAH)  
- Mean Pulmonary Artery Pressure (mPAP)  
- Pulmonary Vascular Resistance (PVR)  
- Pulmonary Capillary Wedge Pressure (PCWP)  
- B‑type Natriuretic Peptide (BNP)  
- N‑terminal pro‑BNP (NT‑proBNP)  
- Right Heart Dysfunction  
- Right Ventricular Enlargement (RVE)  
- Right Atrial Enlargement (RAE)  
- Tricuspid Regurgitation (TR)  
- Tricuspid Annular Plane Systolic Excursion (TAPSE)  
- Right Ventricular Outflow Tract (RVOT)  
- Electrocardiogram (ECG)  
- Transthoracic Echocardiography  
- Cardiac Magnetic Resonance Imaging (CMR)  
- Cardiac Computed Tomography (CT)  
- Exercise Testing (6‑minute walk)  
- Hemodynamic Assessment (right heart catheterization)  
- Pulmonary Hypertension Guidelines  
- Risk Assessment / Risk Stratification  
- PAH‑directed Therapy  
- Fenestrated Patch Closure  
- Balloon Test Occlusion  
- Device Erosion  
- Shunting  
- Desaturation with exercise  
- Functional Capacity  
- Congestion  
- Abdominal Distention  
- Early Satiety  
- Cyanosis  
- Clubbing  
- Accentuated S2 Heart Sound  
- Jugular Venous Distention  
- Peripheral Edema

Page 37 Extracted Terms:
- Atrial septal defect (ASD)  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary vascular resistance (PVR)  
- Left ventricular dysfunction (LV dysfunction)  
- Right heart overcirculation  
- Right-sided chamber enlargement  
- Qp:Qs ratio  
- Pulmonary capillary wedge pressure (PCWP)  
- Tricuspid regurgitation  
- Fenestrated closure  
- Transcatheter closure  
- Surgical closure  
- Hemodynamics  
- Functional capacity  
- Morbidity and mortality  
- 6‑minute walk distance  
- Functional class  
- Paradoxical embolism  
- Thrombophilia  
- Electrophysiology study  
- Partial anomalous pulmonary venous return (PAPVR)  
- Device placement  
- Left atrial pressure  
- Elevated right heart pressure  
- Dual PAH therapy  
- Targeted PAH therapy  
- Residual shunt  
- Reversal of PAH  
- Right ventricular dimensions  
- Direct PAH therapy  
- Specialized PAH management  
- Hemodynamic changes after ASD closure  
- Right ventricular dilatation  

---

Page 38 Extracted Terms:
- Atrial septal defect (ASD)  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary hypertension (PH)  
- Adult congenital heart disease (ACHD)  
- Fenestrated transcatheter device  
- Fenestrated surgical repair  
- Dual up‑front PAH therapy  
- Pulmonary vascular resistance (PVR)  
- Pulmonary arterial pressures (PA pressures)  
- Right ventricle (RV)  
- Left heart disease  
- Wood units (WU)  
- Qp:Qs (pulmonary‑to‑systemic blood flow ratio)  
- Percutaneous fenestrated ASD closure  
- Hemodynamics (optimization)

Page 39 Extracted Terms:
- Superior SVASD  
- Superior vena cava (SVC)  
- Unroofed right upper pulmonary vein  
- Left‑to‑right atrial shunt  
- Transcatheter closure  
- Adult congenital heart disease (ACHD)  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary vascular resistance (PVR) – Wood units  
- Atrial septal defect (ASD)  
- Fenestrated closure  
- Eisenmenger syndrome  
- Ventricular septal defect (VSD)  
- Perimembranous VSD  
- Outlet VSD  
- Double‑chambered right ventricle (DCRV)  
- Right ventricular outflow tract (RVOT) obstruction  
- Qp:Qs ratio  
- Left ventricular (LV) dilation / volume overload  
- Aortic regurgitation  
- Infective endocarditis (with VSD involvement)  
- Transesophageal echocardiography (TEE)  
- Cross‑sectional imaging (e.g., CT/MRI)  
- Sutureless or covered stent closure  
- Treat‑to‑close approach  
- Surgical superior SVASD repair  
- Satisfactory procedural success (>95%)  
- In‑hospital and 30‑day mortality (<1%)  
- Clinical guideline recommendations (B‑NR, C‑LD)  
- Pulmonary hypertension specialist care  

(These terms capture key heart‑disease concepts referenced in the clinical statements and guidelines.)

Page 40 Extracted Terms:
- Ventricular Septal Defect (VSD)  
- VSD closure (surgical or percutaneous)  
- Left‑to‑right shunt  
- Qp:Qs ratio (pulmonary/systemic flow ratio)  
- Pulmonary Arterial Hypertension (PAH)  
- Pulmonary Vascular Resistance (PVR) – Wood units  
- Eisenmenger physiology / Eisenmenger syndrome  
- Left‑ventricular volume overload  
- Left‑ventricular dilatation / hypertrophy  
- Left‑ventricular dysfunction  
- Right‑ventricular dysfunction  
- Pulmonary hypertension (general)  
- Arrhythmia (including complete heart block)  
- Heart failure  
- Infective endocarditis  
- Conduction system disease  
- Transthoracic echocardiography (TTE)  
- Transesophageal echocardiography (TEE)  
- Transcatheter (catheter‑based) closure devices  
- Surgical closure procedures  
- Percutaneous closure procedures  
- Aortic insufficiency / aortic valve disease  
- Prolapse of the right coronary cusp (aortic valve)  
- Sinus of Valsalva aneurysm / prolapse  
- Double‑chambered right ventricle (DCRV)  
- Pulmonary hypertension therapies (pharmacologic)  
- Acute reversibility studies during cardiac catheterization  
- Pulmonary hypertension specialist care  
- Risk stratification for PAH  
- Late post‑closure PAH  
- Residual shunt  
- Complete heart block risk (perimembranous VSD)  
- Wood units (measure of pulmonary vascular resistance)  
- Restrictive VSDs (pressure‑ and/or volume‑restrictive)  
- Non‑restrictive VSDs (large, associated with Eisenmenger)  

Feel free to add any additional terms that you find relevant to your clinical context.

Page 41 Extracted Terms:
- aortic insufficiency  
- sinus of Valsalva aneurysm  
- aortic valve cusp prolapse  
- ventricular septal defect (VSD)  
- aortic regurgitation  
- early aortic valve replacement  
- aortic valve repair  
- Eisenmenger syndrome  
- AR (aortic regurgitation abbreviation)  
- LV (left ventricular)  
- PVR (pulmonary vascular resistance)  
- Qp:Qs (pulmonary‑to‑systemic blood flow ratio)  
- Wood units  
- preventive surgery  
- conservative approach (treatment strategy)

Page 42 Extracted Terms:
- Ventricular septal defect (VSD)  
- Aortic valve replacement  
- Infective endocarditis  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary vascular resistance (PVR)  
- Eisenmenger syndrome  
- Atrioventricular septal defect (AVSD)  
- Left‑ventricular outflow tract obstruction (LVOT obstruction)  
- Left‑ventricular systolic dysfunction  
- Left‑ventricular ejection fraction (LVEF)  
- Cardiopulmonary bypass  
- Pre‑operative PAH therapy  
- Peri‑operative risk  
- Right‑ventricular failure  
- Septic emboli to the lungs  
- Cerebral abscesses  
- Cerebrovascular events  
- Antibiotic prophylaxis  
- Percutaneous closure  
- Surgical closure  
- Right‑heart decompression  
- Atrial fenestration  
- Right‑ventricular volume overload  
- Left‑ventricular volume overload  
- Pulmonary hypertension management  
- Hemodynamic shunt assessment (Qp:Qs)  
- Long‑term PAH therapy  
- Right‑heart monitoring  
- Follow‑up echocardiography  
- Electrocardiogram monitoring  
- Functional status improvement  
- Risk stratification for ACHD patients  
- Adult congenital heart disease (ACHD)  
- Severe PAH with shunt reversal  
- Non‑restrictive VSD  
- Restrictive VSD  
- Unrepaired VSD  
- Residual shunts after repair  
- Ventricular septal defect closure strategy  
- Cardiovascular outcomes in ACHD  
- Complication risk with VSD repair  

These terms capture the core concepts, conditions, interventions, and complications discussed in the provided guideline excerpt.

Page 43 Extracted Terms:
- Atrioventricular septal defect (AVSD)  
- Atrioventricular canal  
- Endocardial cushion defect  
- Partial AVSD (incomplete atrioventricular canal / primum ASD)  
- Complete AVSD (complete atrioventricular canal)  
- Transitional AVSD (transitional atrioventricular canal)  
- Atrioventricular valve regurgitation  
- Left atrioventricular valve regurgitation  
- Left‑ventricular dilation  
- Left‑ventricular systolic dysfunction  
- Left‑ventricular ejection fraction  
- Left‑to‑right shunt (Qp:Qs)  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary vascular resistance (PVR)  
- Eisenmenger physiology  
- Shunt closure  
- Residual shunts  
- Ventricular function  
- Surgical repair (of AVSD, shunt, valve, or LVOT)  
- Reoperation  
- Arrhythmias  
- Conduction abnormalities  
- Complete heart block  
- Electrocardiogram (ECG)  
- Transthoracic echocardiogram (TTE)  
- Cardiac catheterization  
- Adult congenital heart disease (ACHD)  
- Congenital heart defect / disease  
- Pulmonary hypertension  
- Subaortic stenosis  
- Valvular aortic stenosis  
- Left‑ventricular outflow tract (LVOT) obstruction  
- LVOT gradient (peak ≥50 mm Hg, mean ≥40 mm Hg)  
- LV function  
- Atrioventricular node displacement  
- His bundle displacement  
- Left‑axis deviation pattern  
- Late‑onset complete heart block  
- Routine follow‑up / monitoring  
- Pulmonary arterial hypertension guidelines (PAH guidelines)

Page 44 Extracted Terms:
**Key heart‑disease terms extracted from the text**

- Adult Congenital Heart Disease (ACHD)  
- Atrioventricular Canal Defect (AVSD) – partial and complete  
- Left Ventricular Outflow Tract (LVOT) obstruction  
- Mitral (left atrioventricular) valve regurgitation  
- Left Ventricular (LV) dysfunction  
- LV dilation / end‑systolic diameter >40 mm  
- Atrial septal defect (ASD)  
- Ventricular septal defect (VSD)  
- Pulmonary hypertension (PAH)  
- Eisenmenger physiology / syndrome  
- Pulmonary vascular disease  
- Pulmonary outflow tract obstruction (PVR)  
- Anomalous Pulmonary Venous Connections (APVC)  
- Shunt (left‑to‑right, Qp:Qs)  
- Right ventricular (RV) size and function  
- Peak Doppler gradients (≥ 50 mm Hg)  
- Echocardiography / Doppler imaging  
- Cardiovascular magnetic resonance (CMR) imaging  
- Computed tomography (CT) angiography  
- Cardiac catheterization  
- Surgical repair / primary repair / reoperation  
- Reintervention rates  
- Operative mortality / operative risk  
- Residual lesions / residual shunt  
- Symptomatic vs asymptomatic presentation  
- Functional capacity / dyspnea on exertion  
- Surgical indications and guidelines for chronic mitral regurgitation  
- Congenital heart surgeon expertise  
- Long‑term survival rates (e.g., 91–94 % at 15–30 years)  
- Reoperation risk (reoperation frequency, freedom from reoperation)  
- Heart failure as a risk factor for death  

These terms capture the principal clinical concepts, anatomical structures, diagnostic modalities, and outcome metrics related to heart disease discussed in the guideline excerpt.

Page 45 Extracted Terms:
- Adult congenital heart disease (ACHD)  
- Anomalous pulmonary venous connections (APVC)  
- Atrial septal defect (ASD)  
- Right ventricle (RV)  
- Pulmonary arterial hypertension (PAH)  
- Qp:Qs ratio (pulmonary to systemic flow)  
- Cardiac symptoms  
- Reduced functional capacity  
- Surgical repair (pulmonary vein repair)  
- Left‑to‑right shunting (shunts)  
- RV volume overload  
- RV systolic function  
- Invasive measurement (of PAH)  
- Objective exercise intolerance  
- Cardiothoracic surgery (as treatment option)  
- Shunt magnitude  
- Diastolic compliance  
- Pulmonary vein stenosis  
- Warden procedure (repair method)  
- Scimitar vein (variant of APVC)  
- Pulmonary sequestration  
- Patent foramen ovale (implied in shunting context)  
- PA hypoplasia  
- Aortopulmonary collaterals  
- Thrombosis (post‑repair risk)  
- 3‑dimensional cardiovascular magnetic resonance (CMR) imaging  
- Echocardiography (transthoracic and electrocardiogram)  
- Cardiac catheterization angiography  
- Computed tomography (CT) angiography  
- Electrocardiogram (ECG)  
- Transthoracic echocardiogram (TTE)

Page 46 Extracted Terms:
- Atrial partial pulmonary venous connection (APVC)  
- Right ventricle (RV) size  
- Right ventricular function / RV systolic dysfunction  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary hypertension (PH)  
- Pulmonary vein stenosis / baffle stenosis  
- Warden procedure  
- Superior vena cava obstruction  
- Echocardiography (2‑D and Doppler)  
- Cardiovascular magnetic resonance (CMR)  
- Cardiac CT angiography  
- Invasive hemodynamics  
- Cardiac catheterization  
- Left‑to‑right shunt  
- Qp:Qs ratio  
- Pulmonary vascular resistance (PVR)  
- Pulmonary blood flow  
- Cardiopulmonary exercise testing (CPET)  
- Functional capacity  
- Congenital heart disease (CHD) surgeons / congenital heart surgeons  
- Patent ductus arteriosus (PDA)  
- Adult congenital heart disease (ACHD) specialist  
- Pulmonary artery (PA)  
- Right‑ventricular dilation  
- Surgical repair / baffle rerouting  
- Obstructive sleep apnea (risk factor for PH)  
- Intracardiac shunts (other than APVC)  
- Connective tissue disease (cause of PH)  
- Portal hypertension (cause of PH)  
- Age (risk factor for complications)  
- Scimitar syndrome (scimitar vein repair)  

These terms capture the key concepts and clinical factors related to heart disease discussed in the guideline excerpt.

Page 47 Extracted Terms:
- Patent ductus arteriosus (PDA)  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary vascular resistance (PVR)  
- Left ventricular (LV) function  
- Left‑sided chamber size  
- Echocardiography  
- Cardiac magnetic resonance imaging (CMR)  
- Balloon test occlusion  
- Left‑to‑right shunt  
- Right‑to‑left shunt  
- Eisenmenger syndrome  
- Pulmonary hypertension (PH)  
- Pulmonary vasodilators  
- Electrocardiogram (ECG)  
- Transthoracic echocardiogram (TTE)  
- Cardiac catheterization  
- Oxygen saturation measurement (oximetry)  
- Hemodynamic assessment  
- Clinical outcomes (morbidity/mortality)  
- Left heart enlargement / dilation  
- Ventricular dilation / dysfunction  
- Chamber dilation  
- Pulmonary overcirculation  
- Systemic resistance  
- Pulmonary capillary wedge pressure (PCWP)  
- Mean pulmonary artery pressure (mPAP)  
- Wood units  
- Device closure (PDA closure)  
- Unrepaired PDA  
- Adult congenital heart disease (ACHD)

Page 48 Extracted Terms:
- Adult congenital heart disease (ACHD)  
- Patent ductus arteriosus (PDA)  
- Echocardiography  
- Cardiac magnetic resonance imaging (CMR)  
- Flow assessment (Qp:Qs)  
- Left ventricular (LV) volume  
- LV function  
- Ductal anatomy  
- LV remodeling  
- LV dysfunction  
- Pulmonary hypertension (PH)  
- Pulmonary arterial hypertension (PAH)  
- Transcatheter device closure  
- Cardiac computed tomography (CT)  
- Aortic arch  
- Pulmonary vascular resistance (PVR)  
- Wood units (WU)

Page 49 Extracted Terms:
- Pulmonary arterial saturation  
- PDA insertion point  
- Pulmonary blood flow  
- Pulmonary vascular resistance (PVR)  
- Pulmonary arterial hypertension (PAH)  
- Catheter‑based calculation  
- Transpulmonary gradient  
- Hybrid techniques  
- Cardiac magnetic resonance imaging (CMR)  
- Balloon test occlusion  
- Ductus closure tolerability  
- Pulmonary arterial pressure  
- Aortic pressure  
- Left ventricular enlargement  
- Left ventricular dysfunction  
- Endarteritis  
- Percutaneous closure  
- Surgical closure  
- Net left‑to‑right shunt  
- Net right‑to‑left shunt  
- Pulmonary hypertension expertise  
- PVR Wood units (e.g., 2–5, <5, <10, >8, >10)  
- Pulmonary systolic pressure  
- Left atrial hypertension  
- Cor triatriatum sinister  
- Transesophageal echocardiography  
- Cross‑sectional imaging  
- Membrane orifice  
- Pulmonary vein stenosis  
- Atrial fibrillation  
- Atrial flutter  
- Left atrial thrombus  
- Stroke  
- Chronic anticoagulation  
- Congenital cardiac defects  
- Volume overload  
- Hemodynamically insignificant shunt  
- Mortality and morbidity risks  
- Progressive LV enlargement  
- PAH progression  
- Transpulmonary gradient measurement  
- Pulmonary blood flow measurement

Page 50 Extracted Terms:
- Cor triatriatum sinister  
- Congenital heart disease  
- Adult congenital heart disease (ACHD)  
- Unrepaired cor triatriatum sinister  
- Cor triatriatum membrane  
- Fenestrated fibromuscular membrane  
- Left atrial hypertension  
- Left atrial appendage  
- Mitral valve  
- Mitral stenosis (shared pathophysiology)  
- Mitral regurgitation (progression)  
- Atrial fibrillation  
- Atrial flutter  
- Atrial septal defect (ASD)  
- Persistent left superior vena cava  
- Partial anomalous pulmonary venous return (PAPVR)  
- Pulmonary vein stenosis  
- Pulmonary hypertension  
- Pulmonary arterial wedge pressure  
- Left ventricular diastolic pressure  
- Heart failure (gradual onset)  
- Dyspnea on exertion  
- Orthopnea  
- Palpitations  
- Systemic thromboembolism  
- Cardioembolic events  
- Surgical membrane resection  
- Catheter‑based intervention (bridge to surgery)  
- Rhythm control strategy  
- Chronic anticoagulation  
- Transesophageal echocardiography (TEE)  
- Transthoracic echocardiography (TTE)  
- Three‑dimensional echocardiography (3‑DE)  
- Cardiac magnetic resonance imaging (CMR)  
- Computed tomography angiography (CTA)  
- Cardiac catheterization  
- Fibrotic degeneration of the cor membrane  
- Calcification of the cor membrane  
- Fenestrated/obstructive membrane orifice  
- Clinical sequelae of left atrial hypertension  
- Residual anatomical abnormalities post‑repair  
- Intracardiac repair of congenital defects  
- Multimodality imaging for cor triatriatum sinister  
- Routine follow‑up (physiological stages A–D)  
- Electrocardiogram (ECG) monitoring  
- Transthoracic echocardiogram (TTE) follow‑up  
- 3‑D imaging of atrial chambers  
- Clinical decompensation  

(*Terms are extracted to highlight key heart‑disease concepts and related clinical interventions, diagnoses, imaging modalities, and complications discussed in the guideline text.*)

Page 51 Extracted Terms:
- **Cor triatriatum sinister**  
- **Left atrial membrane**  
- **Systemic thromboembolism**  
- **Paradoxical embolism**  
- **Atrial fibrillation**  
- **Pulmonary hypertension (PAH)**  
- **Mitral stenosis**  
- **Congenital mitral stenosis**  
- **Parachute mitral valve**  
- **Supravalvar mitral ring**  
- **Double‑orifice mitral valve**  
- **Shone complex**  
- **Atrial septal defect (ASD)**  
- **Pulmonary venous stasis**  
- **Chronic anticoagulation**  
- **Warfarin**  
- **Direct oral anticoagulants (DOACs)**  
- **Intravenous anticoagulation**  
- **Surgical resection**  
- **Transcatheter ablation**  
- **Maze operation**  
- **Cardiopulmonary bypass**  
- **Heart failure**  
- **Pulmonary edema**  
- **Pregnancy‑associated cardiac risk**  
- **Postpartum cardiac decompensation**  
- **Percutaneous balloon dilatation**  
- **Atrial septal dilation**  
- **Mitral valve injury**  
- **Cardiac perforation**  
- **Left‑heart obstructive lesions**  
- **Invasive hemodynamic assessment**  
- **Pulmonary over‑pressure**  
- **Cor triatriatum membrane regrowth**  
- **Hemodynamically severe obstruction** (≥15 mm Hg gradient)  
- **Noninvasive Doppler interrogation**  
- **Intracardiac repair**  
- **Congenital heart disease (ACHD)**  
- **Maternal and fetal cardiac risk**  
- **Acute pulmonary hypertension**  
- **Cardiac operative risk**

Page 52 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Congenital mitral valve disease  
- Mitral valve prolapse  
- Balloon mitral valvuloplasty  
- Mitral stenosis  
- Atrioventricular septal defect (AVSD)  
- Left atrioventricular valve regurgitation  
- Shone complex  
- Pulmonary hypertension  
- Pre‑capillary pulmonary hypertension  
- Post‑capillary pulmonary hypertension  
- Right heart catheterization  
- Subaortic stenosis  
- Exercise stress testing  
- Surgical repair (membrane resection, myectomy)  
- Left ventricular (LV) dysfunction  
- LV hypertrophy  
- Aortic regurgitation  
- Aortic valve stenosis  
- Membranous obstruction (subaortic obstruction)  
- Mitral valve attachments  
- Endocardial cushion tissue  
- Hypertrophic cardiomyopathy  
- Heart block  
- Reoperation (surgical recurrence)  
- Echocardiogram / Transthoracic echocardiogram  
- Electrocardiogram (ECG)  
- ACHD cardiologist (clinical follow‑up)

Page 53 Extracted Terms:
**Key terms related to heart disease**

- Subaortic stenosis  
- Aortic stenosis  
- Congenital left ventricular outflow tract (LVOT) obstruction  
- LVOT gradient  
- Left ventricular outflow tract (LVOT)  
- Left ventricular hypertrophy (LVH)  
- Left ventricular dysfunction (LVD)  
- Left ventricular remodeling  
- Aortic regurgitation (AR)  
- Bicuspid aortic valve (BAV)  
- Coarctation of the aorta (COA)  
- Aortic aneurysm  
- Aortic dissection  
- Valve replacement  
- Transcatheter aortic valve replacement (TAVR)  
- Adult congenital heart disease (ACHD)  
- Exercise stress testing  
- Exercise stress echocardiography  
- Electrocardiogram (ECG)  
- Transthoracic echocardiogram (TTE)  
- Doppler echocardiography  
- Peak gradient  
- Threshold gradient (e.g., ≥ 50 mm Hg, ≥ 80 mm Hg)  
- Surgical repair of subaortic stenosis  
- Prophylactic surgery  
- Survival rate  
- Intervention‑free survival  
- Risk factor for aortic dissection  
- Surveillance for thoracic aortic disease  
- Physiological stages (A, B, C, D) in ACHD follow‑up  
- Follow‑up intervals (outpatient, ECG, TTE)  
- Screening for congenital aortic valve abnormalities  
- Shared decision‑making for valve therapy  

These terms capture the primary disease entities, diagnostic and therapeutic modalities, risk stratification concepts, and guideline‑specific recommendations discussed in the text.

Page 54 Extracted Terms:
- Bicuspid aortic valve (BAV)
- Congenital aortic valve stenosis
- Aortic regurgitation
- Balloon valvuloplasty
- Aortic valve surgery
- Aortic valve replacement
- Transcatheter aortic valve replacement (TAVR)
- Aortic dissection
- Aortic dilation / aortic enlargement
- Aortic root dilatation
- Coarctation of the aorta (COA)
- Root phenotype aortopathy
- Left ventricular (LV) remodeling
- Left ventricular ejection fraction (LVEF)
- Hypoplastic left heart syndrome (HLHS)
- Truncus arteriosus
- Turner syndrome
- Shone complex
- NOTCH1 gene mutation
- ADAMTS19 gene mutation
- SMAD6 gene mutation
- ROBO4 gene mutation
- NT-proBNP (biomarker)
- Echocardiography
- Cardiac‑gated CT angiography
- Magnetic resonance angiography (MRA)
- Cardiovascular magnetic resonance (CMR)
- Thoracic aortic disease
- Aortic valve disease
- Aortic annulus
- Aortic arch
- Aortic valve imaging intervals
- Aortic valve surgical planning
- Familial inheritance (autosomal dominant pattern)
- Variable penetrance
- Aortic valve repair
- Aortic valve replacement criteria
- Aortic valve hemodynamics (Vmax, ΔP)
- Aortic diameter thresholds (4–5 cm)
- Aortic growth rate ≥ 0.3 cm/year
- Family history of aortic dissection
- Family history of thoracic aortic disease
- History of COA (coarctation of the aorta)
- Periodic imaging surveillance
- Aortic valve surgical durability in young patients
- Aortic valve intervention age considerations
- Coronary artery disease (implicit in cardiovascular context)

Page 55 Extracted Terms:
**Key terms related to heart disease (from the provided guideline excerpt)**  

- Bicuspid aortic valve (BAV)  
- Thoracic aortic disease  
- Aortic valve abnormality  
- Aortic valve interventions  
- Valve repair  
- Ross operation  
- Bioprosthetic valve replacement  
- Mechanical valve replacement  
- Transcatheter aortic valve replacement (TAVR)  
- Congenital heart disease (CHD)  
- Aortic valve replacement (AVR)  
- Aortic valve stenosis  
- Aortic valve regurgitation  
- Calcified aortic valve stenosis  
- Balloon valvuloplasty / balloon dilation of the aortic valve  
- Supravalvar aortic stenosis (SVAS)  
- Williams syndrome  
- Coronary ostial stenosis  
- Coronary artery revascularization  
- Left ventricular (LV) systolic function / LV dysfunction  
- Ventricular function (general)  
- Left ventricular outflow tract (LVOT) obstruction  
- Baseline aortic imaging  
- Baseline coronary imaging  
- Transthoracic echocardiography (TTE) with Doppler  
- Peak and mean pressure gradients across aortic stenosis  
- Surgical repair of SVAS or valve  
- Redo sternotomies  
- Transplantation (cardiac transplant)  
- Reproductive issues & pregnancy considerations in valve disease  
- Sports participation & lifestyle changes in cardiac patients  
- Sudden cardiac death (SCD) risk assessment  
- Clinical decision‑making & shared decision‑making processes in cardiac care  

These terms capture the primary disease processes, diagnostic modalities, therapeutic interventions, and clinical considerations discussed in the guideline text.

Page 56 Extracted Terms:
- Supravalvar aortic stenosis  
- Adult congenital heart disease (ACHD)  
- Williams syndrome  
- Coronary ostial stenosis  
- Coronary artery dilation  
- Coronary artery obstruction  
- Coronary artery anomalies  
- Coronary artery abnormalities (diffuse stenosis, obstruction)  
- Coronary ischemia  
- Ischemic heart disease  
- Arrhythmia  
- Heart failure  
- Left ventricular systolic dysfunction  
- Left ventricular dysfunction  
- LVOT (left ventricular outflow tract) obstruction  
- Aortic valve stenosis  
- Sinotubular junction  
- Aortic valve leaflet adhesion  
- Fibrotic thickening around coronary ostia  
- Coronary revascularization  
- Surgical repair (aortic or coronary)  
- Transesophageal echocardiography  
- Transthoracic echocardiography  
- Cardiovascular magnetic resonance (CMR)  
- MR angiography  
- CT angiography  
- Electrocardiography (ECG)  
- Exercise stress testing  
- Electrocardiogram‑gated coronary CT angiography  
- Invasive coronary angiography  
- Cardiologist follow‑up (ACHD cardiologist)  
- Screening for coronary artery anomalies  
- ELN gene (elastin) – elastin arteriopathy  
- Reintervention rates  
- Long‑term ventricular function  
- Coronary perfusion impairment  
- Coronary artery stenosis (ostial)  
- Coronary artery diastolic filling  
- Coronary artery systolic pressure exposure  
- Anatomic variability  
- Cardiovascular imaging  
- Clinical guidelines  

These terms capture the key heart‑disease concepts referenced in the guideline text.

Page 57 Extracted Terms:
**Key terms related to heart disease in the guideline**

- Coarctation of the Aorta (COA)  
- Unrepaired COA  
- Repaired COA  
- Aortic isthmus stenosis  
- Aortic arch hypoplasia  
- Bicuspid aortic valve (BAV)  
- Left ventricular outflow tract (LVOT) disease  
- Subaortic stenosis  
- Supra‑valvar aortic stenosis  
- Supra‑valvar mitral stenosis  
- Parachute mitral valve  
- Endothelial dysfunction  
- Abnormal smooth‑muscle reactivity  
- Sympathetic hyperactivity  
- Left ventricular (LV) pressure overload  
- LV remodeling (hypertrophy, fibrosis, impaired relaxation, impaired compliance, impaired contractility)  
- Hypertension  
- Blood pressure measurement (upper vs lower extremities)  
- Ambulatory blood pressure monitoring  
- Exercise testing (exercise‑induced hypertension)  
- Coronary artery disease  
- Intracranial aneurysms (brain MRI/CT angiography)  
- Echocardiography – transthoracic Doppler mean gradient  
- Cardiac catheterization (COA peak‑to‑peak gradient)  
- Transcatheter stent therapy  
- Surgical repair/stent therapy  
- Guideline‑directed medical therapy (GDMT) for hypertension  
- Electrocardiogram (ECG)  
- Cardiovascular magnetic resonance (CMR)  
- Computed tomography (CT) angiography (CTA)  
- Magnetic resonance angiography (MRA)  
- Diagnostic indices:  
  - Upper‑to‑lower extremity systolic BP gradient >20 mm Hg  
  - Doppler mean gradient >20 mm Hg  
  - Corrected COA gradient >20 mm Hg  
  - COA peak‑to‑peak gradient >20 mm Hg  
  - Aortic isthmus ratio <0.5–0.7  
  - Collateral arteries  
- Angiogram (plain imaging of aorta)  
- Physiological stages of follow‑up (Stages A–D)  
- ACHD (Adult Congenital Heart Disease)  
- LV dysfunction from chronic pressure overload  
- Aortic root/ascending aorta aneurysms  
- Focal aortic aneurysm, pseudoaneurysm, dissection  
- Stent fracture  
- Upper‑lower extremity systolic blood pressure gradient  
- Diastolic tail in descending aorta  
- Diastolic forward flow in abdominal aorta  

These terms capture the core clinical aspects, diagnostic modalities, and management strategies discussed in the text.

Page 58 Extracted Terms:
- Aortic coarctation (COA)  
- Aortic arch anatomy  
- Ascending aorta dimensions  
- Left ventricular (LV) remodeling  
- LV diastolic dysfunction  
- LV systolic dysfunction  
- Left atrial dysfunction  
- Heart failure with preserved ejection fraction (HFpEF)  
- Pulmonary hypertension  
- Atrial fibrillation  
- Premature coronary artery disease  
- Stroke  
- Re‑coarctation (restenosis of aortic isthmus)  
- Aortic aneurysm  
- Pseudoaneurysm  
- Aortic dissection  
- Systemic hypertension  
- Hypertension screening (office, home, ambulatory)  
- LV hypertrophy (cardiomyocyte hyperplasia)  
- LV pressure overload  
- Myocardial ischemia  
- Replacement fibrosis  
- Exercise‑induced hypertension  
- CPET (cardiopulmonary exercise testing)  
- Exercise‑induced arrhythmias  
- Vascular complications (wall injury, remodeling)  
- Longitudinal imaging surveillance (transthoracic echocardiography, CMR, CT angiography)

Page 59 Extracted Terms:
- Coarctation of the aorta (COA)  
- Hypertension (systemic and exercise‑induced)  
- Antihypertensive therapy  
- Ambulatory blood pressure monitoring  
- Exercise testing  
- Coronary artery disease (CAD)  
- Myocardial infarction  
- Atherosclerotic cardiovascular disease  
- Hyperlipidemia  
- Type 2 diabetes mellitus  
- Angina  
- Exertional dyspnea  
- Intracranial aneurysm  
- Magnetic resonance imaging (MRI) of the brain  
- Computed tomography angiography (CTA) of the brain  
- Surgical repair of COA  
- Transcatheter COA repair / stent therapy  
- COA pressure gradient  
- Aortic isthmus ratio (CMR/CT angiography)  
- Cardiac magnetic resonance (CMR) imaging  
- Left ventricular hypertrophy (LVH)  
- Left ventricular dysfunction  
- Left ventricular reverse remodeling  
- Cardiovascular events  
- Ebstein anomaly  
- Electrophysiological study  
- Arrhythmia  
- Electrophysiological ablation  
- Ventricular preexcitation  
- Right ventricular (RV) dimensions  
- Right ventricular systolic function  
- Stent fracture  
- Restenosis  
- Aneurysm/pseudoaneurysm  
- Reintervention risk  
- Institutional expertise in congenital heart disease (CHD)  
- Cardiovascular surgery  
- Interventionist procedures for CHD  

(Each item is a key term or concept related to heart disease extracted from the provided guideline text.)

Page 60 Extracted Terms:
- Ebstein anomaly  
- Tricuspid valve morphology & function  
- Tricuspid regurgitation  
- Right ventricular (RV) dysfunction  
- RV systolic dysfunction  
- Cardiac output  
- Heart failure  
- Exercise capacity (functional status)  
- Atrial tachyarrhythmias  
- Ventricular tachyarrhythmias  
- Accessory pathways (pre‑excitation)  
- Sudden cardiac death (SCD)  
- Catheter ablation  
- Electrophysiological (EP) study  
- Tricuspid valve surgery  
- Bidirectional superior cavopulmonary (Glenn) anastomosis  
- Atrial septal defect (ASD)/Patent foramen ovale (PFO)  
- Cyanosis  
- Paradoxical embolism  
- Right‑to‑left atrial shunt  
- Multimodality imaging  
- Transthoracic echocardiography (TTE)  
- Transesophageal echocardiography (TEE)  
- Cardiovascular magnetic resonance (CMR)  
- Electrocardiogram (ECG)  
- Pulmonary stenosis (associated defect)  
- Ventricular pre‑excitation  
- Adult congenital heart disease (ACHD)  
- Congenitally corrected transposition of the great arteries (CCTGA)  

These terms capture the central heart‑disease concepts referenced in the guideline text.

Page 61 Extracted Terms:
- Ebstein anomaly  
- Right atrial enlargement  
- Right ventricular (RV) dysfunction  
- Tricuspid regurgitation (TR)  
- Preexcitation  
- Accessory pathways (concealed and manifest)  
- Supraventricular tachycardia (SVT)  
- Ventricular tachycardia (VT)  
- Sudden cardiac death (SCD)  
- Cardiopulmonary exercise testing (CPET)  
- Cardiovascular magnetic resonance (CMR)  
- Transthoracic echocardiography (TTE)  
- Transesophageal echocardiography (TEE)  
- 3‑dimensional echo imaging  
- Cone procedure (tricuspid valve repair)  
- Bidirectional superior cavopulmonary (Glenn) shunt  
- Cardiac computed tomography (CT)  
- Catheter ablation (electrophysiologic testing)  
- Arrhythmia surgery  
- Atrial septal defect (ASD) closure  
- Patent foramen ovale (PFO) closure  
- Left ventricular hypertrophy (LVH)  
- Diastolic dysfunction  
- Pulmonary arterial hypertension  
- Hemodynamic assessment  
- RV volume loading  
- Myopathic process in Ebstein anomaly  
- Pre‑operative catheterization for shunt feasibility  
- Reverse remodeling after surgical repair  
- Risk stratification  
- Surgical repair of tricuspid valve (repair versus replacement)  
- Valve‑in‑valve catheter intervention  
- Proactive intervention strategy  

These terms capture the key cardiovascular disorders, diagnostic modalities, and therapeutic interventions discussed in the guideline text.

Page 62 Extracted Terms:
- Ebstein anomaly  
- Ventricular pre‑excitation  
- Accessory pathways  
- High‑risk pathways  
- Sudden cardiac death (SCD)  
- Catheter ablation  
- Surgical interruption of accessory pathways  
- Atrial arrhythmias  
- Systemic desaturation  
- Tricuspid regurgitation (TR)  
- Right‑ventricular (RV) dysfunction  
- Tricuspid valve surgery  
- Atrial septal defect (ASD) closure  
- Patent foramen ovale (PFO) closure  
- Arrhythmia surgery (e.g., Maze procedures)  
- Right‑atrial Maze procedure  
- Left‑atrial Cox Maze III procedure  
- Balloon valvuloplasty (pulmonary)  
- Pulmonary valve replacement (PVR)  
- Valvular pulmonary stenosis (PS)  
- Pulmonary valve intervention  
- Pulmonary stenosis severity (moderate/severe)  
- RV pressure overload  
- Cyanosis  
- Paradoxical embolism  
- Hemodynamics (intracardiac pressures, cardiac output)  
- Cardiac transplantation  
- Bidirectional cavopulmonary shunt (Glenn shunt)  
- Multidisciplinary team evaluation  
- Genetic syndromes (e.g., Noonan syndrome)  
- Dilated main pulmonary artery (PA)  
- Dysplastic pulmonary valve cusps  
- Symptomatic vs. asymptomatic pulmonary stenosis  
- Percutaneous device closure  
- Ventricular arrhythmias  
- Atrial fibrillation  
- Stroke volume support by RV  
- Pediatric vs. adult surgical indications  
- Interventional cardiology techniques  
- Surgical risk assessment  
- Valve anatomy (favorable/unfavorable)  
- Suboptimal valvuloplasty results  

These are the principal terms related to heart disease extracted from the guideline text.

Page 63 Extracted Terms:
**Key heart‑disease terms extracted from the guideline text**

- Pulmonary valve stenosis  
- Pulmonary valve regurgitation  
- Pulmonary balloon valvuloplasty  
- Valvuloplasty (general)  
- Surgical pulmonary valvotomy  
- Pulmonary valve replacement  
- Tricuspid valve regurgitation / insufficiency  
- Right‑to‑left shunt  
- Right ventricular outflow tract dysfunction  
- RV systolic dysfunction  
- Exercise‑induced hypoxemia  
- Objective exercise capacity  
- Cyanosis  
- Symptomatic vs. asymptomatic patients  
- Annular hypoplasia  
- Valvular dysplasia  
- Adult congenital heart disease (ACHD)  
- Routine follow‑up for valvular pulmonary stenosis  
- Electrocardiogram (ECG)  
- Transthoracic echocardiogram  
- Cardiovascular magnetic resonance (CMR) imaging  
- Doppler velocity and gradient across the right ventricular outflow tract  
- Peak gradient (mm Hg, m/s)  
- Mean gradient  
- Regurgitant fraction  
- Regurgitant volume  
- Vena contracta  
- Pressure half‑time  
- PR index (pulmonary regurgitation index)  
- Echocardiographic features of pulmonary regurgitation  
- Doppler spectral signal characteristics  
- Exercise capacity decline  
- Follow‑up intervals (physiological stages A–D)  

These terms collectively capture the key anatomical, physiological, diagnostic, and interventional concepts relevant to heart disease discussed in the guideline.

Page 64 Extracted Terms:
- Pulmonary Regurgitation  
- Pulmonary Stenosis  
- Isolated Pulmonary Regurgitation  
- Isolated Pulmonary Stenosis  
- Pulmonary Valve Replacement  
- Transcatheter Pulmonary Valve Implantation  
- Surgical Valvotomy  
- Balloon Valvuloplasty  
- Right Ventricular (RV) Systolic Dysfunction  
- RV Dilation  
- RV Enlargement  
- Right Ventricular (RV) Systolic Function  
- RV Volumes  
- Right Heart Anatomy  
- Cardiac MRI (CMR)  
- Echocardiography  
- Tricuspid Regurgitation  
- Symptoms of Heart Failure  
- Infective Endocarditis  
- Tetralogy of Fallot (TOF)  
- Congenital Heart Disease (CHD)  
- Chronic Pulmonary Regurgitation  
- Pulmonary Valve Insufficiency  
- Right Ventricular Remodeling  
- Reverse Remodeling  
- Pulmonary Valve Gradients  
- Exercise Capacity  
- Late Intervention  
- Early Intervention  
- Surveillance CMR  
- Pulmonary Valve Function  

Page 65 Extracted Terms:
**Key heart‑disease terms extracted from the guideline text**

- Double‑Chambered Right Ventricle (DCRV)  
- DCRV (abbreviation)  
- Right ventricular (RV) dysfunction  
- Right ventricular outflow tract (RVOT) obstruction  
- Cardiac catheterization  
- Cardiovascular magnetic resonance (CMR)  
- Cardiac CT  
- Surgical repair (of DCRV)  
- Heart failure  
- Cyanosis  
- Exercise limitation / intolerance  
- Asymptomatic adult with DCRV  
- Severe RVOT obstruction  
- Right ventricular remodeling  
- Hypertrophied muscle bundles  
- Right ventricular cavity  
- Ventricular septal defect (VSD)  
- Restrictive VSD  
- High‑pressure inlet chamber (RV)  
- Low‑pressure outlet chamber (RV outflow)  
- Intravenous pressure gradient (within RV)  
- Pulmonary regurgitation (PR)  
- Pulmonary stenosis (PS)  
- Tricuspid regurgitation (TR)  
- Dyspnea  
- Chest pain  
- Exercise intolerance attributable to PR or other causes  
- Pulmonary regurgitation after repair of pulmonary stenosis  

These terms capture the core cardiac conditions, diagnostic tools, interventions, and clinical manifestations discussed in the guideline excerpt.

Page 66 Extracted Terms:
- Double‑Chambered Right Ventricle (DCRV)  
- Ventricular Septal Defect (VSD)  
- Right Ventricular Outflow Tract (RVOT)  
- Subpulmonary Stenosis  
- Mid‑RV Obstruction  
- Intramyocardial Muscle Bundles  
- Pressure Gradient (RVOT)  
- Right‑to‑Left Shunting  
- Left‑to‑Right Shunting  
- Echocardiography (Transthoracic)  
- Cardiac Computed Tomography (CT)  
- Cardiovascular Magnetic Resonance (CMR)  
- Cross‑Sectional Imaging  
- Electrocardiogram (ECG)  
- Adult Congenital Heart Disease (ACHD)  
- Pulmonary Artery (PA) Stenosis  
- Peripheral Pulmonary Artery Stenosis  
- Tricuspid Regurgitation  
- Pulmonary Regurgitation  
- Right Ventriculotomy  
- Right Ventricular Dysfunction  
- Ventricular Arrhythmias  
- Surgical Repair (Resection of Obstructive Muscle Bundles)  
- Recurrent DCRV  
- Postoperative Outcomes.

Page 67 Extracted Terms:
- Pulmonary branch stenosis  
- Peripheral pulmonary artery stenosis  
- Right ventricular (RV) hypertension  
- RV dysfunction  
- Tricuspid regurgitation  
- Pulmonary hypertension  
- Right heart failure  
- Cyanosis (atrial‑level right‑to‑left shunting)  
- Balloon angioplasty (pulmonary)  
- Stent implantation (pulmonary)  
- Pulmonary perfusion testing  
- Transthoracic echocardiography  
- Computed tomography (CT)  
- Cardiac magnetic resonance (CMR)  
- Right ventricular pressure  
- Pulmonary blood flow  
- Right ventricular filling pressure  
- Exercise intolerance / exercise tolerance  
- Ventilatory efficiency  
- Pulmonary artery pressure gradient  
- Restenosis  
- Surveillance imaging  
- Adult congenital heart disease (ACHD)  
- Noonan syndrome  
- Alagille syndrome  
- Williams syndrome  
- Maternal rubella exposure  
- Echocardiographic imaging  
- Cross‑sectional imaging  
- Cardiovascular intervention  
- ACHD interventional cardiologist  
- Cardiac surgery (ACHD expertise)  
- Follow‑up intervals for isolated branch pulmonary artery stenosis  

Page 68 Extracted Terms:
- Tetralogy of Fallot (TOF)  
- Repaired Tetralogy of Fallot  
- Pulmonary valve dysfunction (moderate PR, PR >25% by CMR)  
- Pulmonary regurgitation  
- Pulmonary stenosis  
- Right ventricular outflow tract (RVOT) dysfunction  
- Residual ventricular septal defects (VSDs)  
- Tricuspid valve dysfunction / tricuspid regurgitation  
- Right atrial size  
- Right ventricular (RV) size and function  
- Left ventricular (LV) size and function  
- Right ventricular systolic pressure (RVSP)  
- Right ventricular end‑systolic volume index (RVESVI)  
- Right ventricular end‑diastolic volume (RVEDV)  
- Left ventricular ejection fraction (LVEF)  
- Right ventricular ejection fraction (RVEF)  
- Ventricular tachycardia (VT)  
- Ventricular arrhythmia / tachyarrhythmia  
- Sudden cardiac death (SCD)  
- Implantable cardioverter‑defibrillator (ICD)  
- Electrophysiology evaluation  
- Catheter ablation  
- Anti‑arrhythmic therapy (class I/III agents, amiodarone)  
- Electrical cardioversion  
- Defibrillation / ICD shock  
- Pace termination  
- Pulmonary valve replacement (surgical or transcatheter)  
- Transcatheter pulmonary valve placement (balloon‑expandable platform)  
- Pulmonary valve conduit stenting  
- Cardiac catheterization with angiography  
- Echocardiography (including assessment of pulmonary and tricuspid valves, RVOT, etc.)  
- Cardiovascular magnetic resonance (CMR) imaging  
- Cardiac computed tomography (CT) angiography  
- 12‑lead electrocardiography  
- Contrast‑enhanced MR imaging  
- CT angiography  
- Surgical repair of TOF (initial surgery)  
- RVOT anatomy (native vs conduit)  
- Branch pulmonary artery size and flow  
- Aortopulmonary collateral flow  
- Myocardial fibrosis assessment (CMR)  
- Functional tricuspid regurgitation  
- Exercise capacity  

These terms capture the core concepts related to heart disease management and surveillance in adults with repaired Tetralogy of Fallot.

Page 69 Extracted Terms:
- Adult congenital heart disease (ACHD)  
- Tetralogy of Fallot (TOF)  
- Right ventricular (RV)  
- Right ventricular outflow tract (RVOT)  
- Pulmonary valve  
- RV‑to‑PA conduit  
- RVOT dysfunction  
- Branch pulmonary artery stenosis  
- Pulmonary valve dysfunction  
- Primary regurgitation  
- Primary stenosis  
- Mixed pulmonary valve disease  
- Moderate pulmonary regurgitation  
- CMR‑measured regurgitant fraction  
- RV pressure  
- RV systolic pressure  
- Monomorphic ventricular tachycardia (VT)  
- Sudden cardiac death (SCD)  
- QRS duration ≥180 ms  
- QRS fragmentation  
- Inducible sustained ventricular arrhythmia  
- Electrophysiology study  
- Surgical era (pre‑1980 vs. ≥1980)  
- Coronary artery disease  
- Left ventricular ejection fraction (LVEF)  
- LV dysfunction  
- Right ventricular ejection fraction (RVEF)  
- RV volume  
- RV pressure  
- Late gadolinium enhancement (LGE)  
- LV LGE extent  
- RV LGE present  
- NYHA II‑III symptoms / NYHA class  
- Supraventricular tachycardia  
- Systemic EF <40 %  
- Subpulmonary EF <40 %  
- QRS duration ≥120 ms  
- QT dispersion ≥70 ms  
- Shunt pre‑repair  
- Age at repair <6.5 years  
- Peak VO₂ ≤17 mL/kg/m²  
- B‑type natriuretic peptide (BNP) ≥127 ng/L  
- Akinetic RVOT length ≥55 mm  
- RVOT pressure ≥47 mm Hg  
- Implantable cardioverter‑defibrillator (ICD)  
- Ventriculotomy  
- Infundibulotomy  
- Transannular patch  
- RV free wall  
- Fibrosis  
- Scar tissue  
- Aneurysmal area  
- Dyskinetic area  
- Pulmonary valve atresia  
- RVOT obstruction  
- RVOT resection  
- Conduit replacement  
- Pulmonary regurgitation  
- Pulmonary stenosis  
- Ventricular fibrillation (VF)  
- ECG (electrocardiogram)  
- Electrophysiology  
- PREVENTION‑ACHD risk score  
- Brompton risk score  
- PACES risk score

Page 70 Extracted Terms:
- Tetralogy of Fallot (TOF)  
- Repaired TOF  
- Right Ventricular Outflow Tract (RVOT) obstruction  
- Right ventricular (RV) function  
- Pulmonary regurgitation (PR)  
- RV dilation  
- RV dysfunction  
- Tricuspid valve regurgitation (TR)  
- Left ventricular (LV) dysfunction  
- Aortic root dilation  
- Atrial arrhythmias (atrial flutter, atrial fibrillation)  
- Ventricular arrhythmias  
- Monomorphic ventricular tachycardia  
- Sudden cardiac death (SCD)  
- Pulmonary valve replacement  
- Right ventricular systolic pressure (RVSP)  
- Regurgitant fraction (RF)  
- Cardiovascular magnetic resonance (CMR) imaging  
- End‑systolic volume index (ESVi)  
- Left ventricular end‑diastolic volume (LVEDV)  
- Left ventricular ejection fraction (LVEF)  
- Right ventricular end‑diastolic volume (RVEDV)  
- Right ventricular ejection fraction (RVEF)

Page 71 Extracted Terms:
**Key heart‑disease terms extracted from the guideline text**

- Tetralogy of Fallot (TOF)  
- Repaired Tetralogy of Fallot  
- Unrepaired Tetralogy of Fallot  
- Pulmonary atresia  
- Ventricular tachycardia (VT)  
- Sustained monomorphic ventricular tachycardia  
- Ventricular fibrillation (VF)  
- Sudden cardiac death (SCD)  
- Implantable cardioverter‑defibrillator (ICD)  
- Catheter‑based ablation  
- Right ventricular outflow tract (RVOT)  
- Pulmonary valve replacement (PVR)  
- Transcatheter pulmonary valve replacement  
- Balloon‑expandable pulmonary valve  
- Self‑expanding pulmonary valve  
- Coronary artery anomaly (e.g., anomalous LAD from RCA)  
- Coronary artery compression  
- Aortography  
- Coronary angiography  
- Cardiac computed tomography (CT)  
- Cardiovascular magnetic resonance (CMR)  
- Echocardiography (2‑D, 3‑D, M‑mode, strain imaging, Doppler)  
- QRS duration > 180 ms  
- QRS fragmentation  
- Late gadolinium‑enhancement CMR  
- Risk stratification for VT/SCD  
- Electrocardiogram (ECG)  
- Transthoracic echocardiogram  
- Pulmonary regurgitation  
- Ventricular dysfunction (right or left)  
- Symptomatic nonsustained ventricular tachycardia  
- Left ventricular (LV) dysfunction  
- Pulmonary hypertension  
- Cardiac chamber size and function  
- Adult congenital heart disease (ACHD)  

These terms capture the primary clinical entities, imaging modalities, procedural interventions, and risk‑assessment factors discussed in the guideline excerpt.

Page 72 Extracted Terms:
Tetralogy of Fallot (TOF) – repaired TOF  
Pulmonary valve replacement (surgical & transcatheter)  
Pulmonary regurgitation  
Right ventricular dilation / enlargement  
Right ventricular hypertrophy  
Right ventricular dysfunction  
Ventricular tachycardia (VT) – monomorphic, sustained, reentrant  
Sudden cardiac death (SCD)  
Pulmonary artery (PA) pressure  
Pulmonary vascular resistance (PVR)  
Cardiac catheterization  
Echocardiography – diastolic dysfunction  
Electrophysiology study (EPS) – programmed ventricular stimulation  
Catheter ablation – VT substrate ablation, cryoablation  
Electrocardiogram (ECG) – QRS duration, fragmentation, isthmus conduction  
Contrast‑enhanced cardiac magnetic resonance imaging (CMR) – signal intensity, ventricular volume  
Multidetector computed tomography (CT) angiography – wall thickness, coronary anatomy  
Right ventricular end‑diastolic volume (RVEDV) – indexed RVEDV (RVEDVi)  
Right ventricular end‑systolic volume index (RVESVi)  
Right ventricular ejection fraction (RVEF) – threshold <46 %  
Left ventricular ejection fraction (LVEF) – threshold <50 %  
Cardiopulmonary exercise testing (CPET) – functional capacity, exercise tolerance  
Risk stratification scores – conventional risk‑factor analysis, clinical risk scores  
Thresholds for pulmonary valve replacement (RVEDV >80 mL/m², RVEDV ≥2× LVEDV)  
Arrhythmia substrate identification – conduction isthmuses, QRS morphology  
Functional class improvement post‑pulmonary valve replacement.

Page 73 Extracted Terms:
- Tetralogy of Fallot (TOF)  
- Pulmonary valve replacement  
- Right ventricular (RV) dysfunction / dilatation  
- Left ventricular (LV) dysfunction  
- Ventricular tachycardia (monomorphic)  
- Sudden cardiac death (SCD)  
- Implantable cardioverter‑defibrillator (ICD) placement  
- Catheter ablation  
- Cardiac magnetic resonance imaging (CMR) / MRI  
- QRS duration and fragmentation  
- Myocardial scarring  
- Tricuspid regurgitation  
- Heart failure  
- Coronary artery disease  
- Reverse Bernheim effect (ventricular‑ventricular interaction)  
- Ventricular‑ventricular interaction  
- Risk stratification scores  
- Indexed right ventricular end‑diastolic volume (RVEDV)  
- Indexed right ventricular end‑systolic volume (RVESV)  
- Biventricular global function index  
- Heart transplantation  
- Mechanical circulatory support (MCS)  
- Ventricular dysfunction (general)  
- Cardiac arrhythmia  
- Systolic dysfunction  
- Diastolic dysfunction  
- Electrophysiology study / invasive electrophysiology  
- Ventricular remodeling  
- Pulmonary valve dysfunction  
- Tricuspid valve intervention  
- Endocarditis  
- Device lead implantation  
- Annular dilation  
- Ventricular systolic function  
- Ventricular diastolic volume  
- Ventricular end‑systolic volume  
- Ventricular end‑diastolic volume



Page 74 Extracted Terms:
- Tetralogy of Fallot (TOF)  
- Pulmonary regurgitation  
- Ventricular tachycardia  
- Arrhythmia management  
- Pulmonary valve replacement (surgical)  
- Pulmonary valve replacement (transcatheter)  
- Implantable cardioverter‑defibrillator (ICD)  
- Catheter ablation of ventricular tachycardia  
- Pulmonary Atresia with Intact Ventricular Septum (PA‑IVS)  
- Right Ventricular Outflow Tract (RVOT)  
- Tricuspid valve hypoplasia  
- Right ventricular (RV) pressure overload  
- Coronary circulation  
- Coronary sinusoids  
- Coronary fistulas  
- RV‑dependent coronary circulation  
- Biventricular repair  
- 1½ ventricular repair  
- Fontan procedure  
- Cardiac transplantation  
- Shunt palliation  
- Atrial arrhythmias  
- Restrictive RV physiology  
- Ventricular fibrosis  
- Sudden cardiac death (SCD)  
- Heart failure  
- Right atrial function  
- Right atrial strain  
- Hepatorenal dysfunction  
- Cardiovascular death  
- RV‑to‑Pulmonary Artery (RV‑to‑PA) conduit  
- Conduit stent implantation  
- Coronary artery compression  
- Conduit dysfunction  
- Stent fracture  
- Pulmonary stenosis  
- Pulmonary regurgitation (conduit related)  
- Infective endocarditis  
- Thrombus  
- Cardiac catheterization  
- Hemodynamics of RV‑to‑PA conduit  
- Clinical heart failure in PA‑IVS  
- ICD therapies reduction  
- Conduit fracture imaging  
- Conduit dysfunction evaluation  
- Unanticipated conduit dysfunction  
- SCD risk reduction via ablation  
- SCD rate increase with RV‑dependent circulation  
- Management of right atrial strain  
- Clinical outcomes of functional status  
- Management of RV‑to‑PA conduit failure


Page 75 Extracted Terms:
- RV‑to‑PA conduit  
- Transcatheter intervention  
- Coronary CT  
- Conduit calcification  
- Anatomical characteristics  
- Coronary artery proximity  
- Procedural planning  
- Severe stenosis  
- Severe regurgitation  
- Moderate stenosis  
- Moderate regurgitation  
- Sustained arrhythmia  
- Cardiovascular status  
- Tetralogy of Fallot (TOF)  
- Pulmonary atresia  
- Truncus arteriosus  
- Aortic stenosis  
- Transposition of the great arteries (TGA)  
- Ross procedure  
- Rastelli procedure  
- Congenitally corrected transposition of the great arteries (CCTGA)  
- Sano shunt  
- Homograft (aortic or pulmonary)  
- Xenograft  
- Bioprosthetic valve  
- Progressive stenosis  
- Valvular regurgitation  
- Coronary artery compression  
- Coronary compression testing  
- Balloon‑expanded stent  
- Stent fracture  
- Stent fracture‑related stenosis  
- Pulmonary regurgitation  
- Infective endocarditis  
- Transcatheter pulmonary valve (MPV)  
- Routine follow‑up  
- Adult congenital heart disease (ACHD)  
- Electrocardiogram (ECG)  
- Transthoracic echocardiogram (TTE)

Page 76 Extracted Terms:
- Infective endocarditis  
- Cardiac valve implantation  
- RV‑to‑PA conduit  
- Pulmonary stenosis  
- Pulmonary regurgitation  
- Bioprosthetic valve thrombosis  
- Conduit dysfunction  
- Conduit stenosis  
- Conduit regurgitation  
- Stent implantation  
- Transcatheter valve placement  
- Cardiac catheterization  
- Echocardiography  
- Cardiovascular magnetic resonance (CMR) imaging  
- Coronary computed‑tomography (CT) angiography  
- Pulmonary arterial hypertension  
- Right ventricular dysfunction  
- Right ventricular dilation  
- Exercise capacity  
- Arrhythmias (atrial and ventricular)  
- Tricuspid regurgitation  
- Thrombus formation (subclinical)  
- Aspirin therapy  
- Surgical valve replacement  
- Transcatheter valve replacement  
- Hemodynamic assessment  
- Pulmonary arterial pressures  
- Cardiac output  
- Volume status  
- Pulmonary arterial resistance  
- Periprocedural complications  
- Long‑term outcomes  

Page 77 Extracted Terms:
- Dextro‑Transposition of the Great Arteries (d‑TGA)  
- Atrial switch (Surgically induced)
- Systemic right ventricle  
- Tricuspid valve (systemic AV valve)  
- Heart failure  
- Exercise intolerance  
- Pulmonary hypertension  
- Baffle leak  
- Baffle obstruction  
- Ventricular tachyarrhythmia  
- Supraventricular tachyarrhythmia (atrial arrhythmias)  
- Sustained ventricular tachyarrhythmia  
- Sudden cardiac death (SCD)  
- Implantable cardioverter‑defibrillator (ICD)  
- Pacemaker (permanent)  
- Cardiac resynchronization therapy (CRT)  
- Guideline‑directed medical therapy (GDMT) for HFrEF  
- Anticoagulation (oral)  
- Transcatheter valve placement  
- Balloon‑expandable percutaneous valves  
- Self‑expanding valve technologies  
- Conduit intervention  
- Complex congenital lesions  
- Right ventricular ejection fraction (RVEF)  
- Systemic venous pathway stenosis  
- Pulmonary venous pathway stenosis  
- Exercise capacity improvement  
- Transthoracic echocardiography (TTE)  
- Cardiac magnetic resonance imaging (CMR)  
- Cardiopulmonary exercise testing (CPET)  
- Invasive hemodynamic assessment  
- Electrocardiogram (ECG)  
- Ambulatory rhythm monitoring  
- Catheter‑based interventions for residual lesions  
- Risk score application for ventricular arrhythmia & SCD  
- Mechanical circulatory support (MCS)  
- Transplantation (heart‑lung, heart).

Page 78 Extracted Terms:
- Regurgitation (moderate or severe)  
- Exercise intolerance  
- Heart failure  
- Ventricular dysfunction  
- Valve dysfunction  
- Chronotropic incompetence  
- Pathway obstruction  
- Baffle leaks  
- Arrhythmia (atrial, ventricular)  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary hypertension (post‑capillary, pre‑capillary, combined)  
- Stenosis of pulmonary and systemic venous pathways  
- Pulmonary or systemic venous congestion  
- Left‑to‑right shunting  
- Ventricular overload  
- Bidirectional shunting  
- Cyanosis  
- Paradoxical emboli  
- Atrial arrhythmias (28.9% prevalence)  
- Ventricular arrhythmias (5.8% prevalence)  
- Sudden death  
- Loss of sinus rhythm  
- Permanent pacing / pacemaker  
- Transthoracic echocardiography (TTE)  
- Cardiovascular magnetic resonance (CMR)  
- Late gadolinium enhancement (LGE)  
- Myocardial scar  
- Cardiac catheterization  
- Electrocardiogram (ECG) / Holter monitoring  
- Peak oxygen consumption (VO₂)  
- Ventilation to CO₂ output slope  
- CPET (cardiopulmonary exercise testing)  
- Exercise‑induced cyanosis  
- Tachyarrhythmias  
- Bradyarrhythmias  
- Pulmonary venous pathways  
- d‑TGA (dextro‑transposition of the great arteries)  
- ACHD (adult congenital heart disease)  
- Atrial switch operation  
- Systemic right ventricle (RV) function  
- Tricuspid regurgitation  
- Venous return pathways  
- Stent or closure device (artifact in imaging)  

These terms capture the cardiovascular conditions, diagnostic modalities, and relevant clinical considerations presented in the guideline excerpt.

Page 79 Extracted Terms:
**Key heart‑disease terms extracted from the text**

- Pulmonary hypertension  
- Advanced heart failure  
- Heart–lung transplantation  
- Permanent pacemaker (PPM)  
- Implantable cardioverter‑defibrillator (ICD)  
- Transvenous pacing leads  
- Subcutaneous ICD  
- Cardiac resynchronization therapy (CRT)  
- d‑Transposition of the great arteries (d‑TGA)  
- Atrial switch (Senning/Mustard procedures)  
- Superior vena cava (SVC) pathway  
- Azygos vein (off‑loading pathway)  
- Baffle leak (intratrial)  
- Thromboembolic complications (related to baffle leaks)  
- Ventricular arrhythmia  
- Atrial arrhythmia  
- Supraventricular arrhythmia  
- Left ventricular (LV) dysfunction  
- Right ventricular (RV) dysfunction  
- Severe tricuspid regurgitation  
- Sudden cardiac death (SCD)  
- Malignant arrhythmias (e.g., sustained ventricular tachycardia)  
- ICD therapy (appropriate shocks)  
- Holter monitoring  
- Implantable loop recorder  
- Intra‑atrial reentrant tachycardia (IART)  
- Electrical cardioversion  
- Antiarrhythmic drug therapy  
- Catheter ablation (including 3‑D imaging, mapping, robotic magnetic navigation)  
- Baffle‑leak intervention (e.g., closure procedures)  
- Left‑to‑right shunt (clinical significance)  
- QRS duration (≥120 ms)  
- LVOT obstruction  
- Risk stratification for mortality and major events  

These terms capture the major cardiovascular conditions, interventions, and risk‑assessment elements discussed in the guideline excerpt.

Page 80 Extracted Terms:
**Key heart‑disease terms extracted from the guideline text**

- Left‑ventricular (LV) volume overload  
- Right‑to‑left shunting  
- Cyanosis at rest or with exercise  
- Paradoxical emboli  
- Baffle leak  
- Pulmonary congestion  
- Systemic right‑ventricle (RV) dysfunction  
- Tricuspid regurgitation (TR)  
- Systemic venous pathway stenosis  
- Superior vena cava (SVC) stenosis  
- Inferior vena cava (IVC) stenosis  
- De‑xtro‑transposition of the great arteries (d‑TGA)  
- Atrial switch repair  
- Progressive systemic RV dysfunction  
- Heart failure (HF)  
- Refractory arrhythmias  
- Cardiac transplantation  
- Mechanical circulatory support (MCS)  
- Intravenous diuretics  
- Pulmonary vascular resistance (PVR)  
- Tricuspid valve repair / replacement  
- Permanent pacemaker implantation  
- Implantable cardioverter‑defibrillator (ICD) implantation  
- CHA₂DS₂‑VASc score  
- Anticoagulation (vitamin K antagonists, direct oral anticoagulants)  
- Echocardiography (transthoracic, transesophageal, agitated saline test)  
- Cardiac resynchronization therapy (CRT)  
- Renin–angiotensin–aldosterone system (RAAS) inhibitors  
- Beta‑blockers  
- Phosphodiesterase‑5 inhibitor (tadalafil)  
- Sacubitril/valsartan  
- Dapagliflozin.

Page 81 Extracted Terms:
- Adult congenital heart disease (ACHD)  
- Arterial switch operation  
- d‑TGA (dextro‑transposition of the great arteries)  
- Neoaortic size/diameter  
- Neoaortic root dilation  
- Neoaortic regurgitation (insufficiency)  
- Neoaortic valve stenosis  
- Neoaortic valvular dysfunction  
- Neoaortic root replacement  
- Supravalvar pulmonary artery stenosis  
- Branch pulmonary artery stenosis  
- Coronary artery anatomy  
- Coronary obstruction  
- Coronary angiography  
- Coronary revascularization  
- Myocardial ischemia  
- Echocardiography  
- Cardiovascular magnetic resonance (CMR)  
- Cardiac computed tomography (CT)  
- Right ventricular hypertension  
- Right ventricular dysfunction  
- Tricuspid regurgitation  
- Exercise capacity  
- Aortic valve disease  
- Late postoperative complications  
- Routine follow‑up intervals  
- Monitoring of pulmonary artery anatomy  
- Monitoring of ventricular function  
- Monitoring of valve function  
- Monitoring of coronary artery patency  

Page 82 Extracted Terms:
- Neoaortic diameter  
- Branch pulmonary artery (PA) stenosis  
- Cardiac Magnetic Resonance Imaging (CMR)  
- Cardiac Computed Tomography (CT)  
- Regadenoson stress CMR perfusion  
- Arterial switch operation  
- Coronary artery assessment  
- Coronary reintervention  
- Ventricular tachycardia (VT)  
- Sudden cardiac death (SCD)  
- Intra‑mural course  
- Acute angulation of the left coronary artery  
- Clockwise rotation of the left coronary ostium  
- Distance between left coronary ostium and neopulmonary artery  
- Lecompte maneuver  
- Aortic dilation/enlargement  
- Right ventricular (RV) pressure load  
- Neoaortic root intervention  
- Neoaortic insufficiency (regurgitation)  
- Neoaortic regurgitation  
- Root diameter  
- Aortic dissection  
- Bicuspid aortic valve (BAV)  
- Connective tissue disease  
- Valve‑sparing aortic root replacement  
- Cardiac catheterization  
- Dynamic obstruction  
- Perfusion imaging  
- Pulmonary valve stenosis  
- Transcatheter intervention  
- Aortopulmonary fistula  
- Exercise capacity  
- Functional status  
- Symptomatic ischemia  
- Exertional dyspnea  
- Interventional cardiology  
- Heart disease imaging modalities  

Page 83 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Dextro‑Transposition of the Great Arteries (d‑TGA)  
- Rastelli Repair/Operation  
- Ventricular Septal Defect (VSD)  
- Right Ventricular–to‑Pulmonary Artery (RV‑to‑PA) Conduit  
- Left Ventricular Outflow Tract (LVOT) Obstruction  
- Right Ventricular (RV) Dysfunction (systolic and diastolic)  
- Aortic Dissection  
- Neo‑aortic Root Diameter  
- Prophylactic Root Replacement  
- Thoracic Aortic Disease  
- Arrhythmia  
- Heart Failure  
- Right Ventricular Outflow Tract (RVOT) Obstruction  
- Pulmonary Regurgitation (pulmonary insufficiency)  
- Neo‑aortic Insufficiency  
- Coronary Artery Stenosis  
- Infective Endocarditis  
- Conduit Stenosis  
- Conduit Insufficiency / Calcification  
- Residual VSD  
- RV Pressure/Volume Overload  
- Tricuspid Regurgitation Velocity  
- RV Hypertrophy  
- RV Dilatation  
- Transthoracic Echocardiography (Echo)  
- Cardiac Magnetic Resonance Imaging (CMR)  
- Cardiac Computed Tomography Angiography (CT angiography)  
- Electrocardiogram (ECG)

Page 84 Extracted Terms:
- Congenitally Corrected Transposition of the Great Arteries (CCTGA)  
- Atrioventricular (AV) block  
- Systemic tricuspid valve dysfunction / regurgitation  
- Systemic ventricular dysfunction (right‑ventricular systolic dysfunction)  
- Subpulmonic left‑ventricular dysfunction  
- Left‑ventricular outflow tract (LVOT) stenosis / obstruction  
- Right‑ventricular systolic dysfunction  
- Right‑ventricular systolic dysfunction prevalence (50–80%)  
- Left‑ventricular systolic dysfunction prevalence (11–40%)  
- Ventricular arrhythmias (atrial and ventricular)  
- Cardiac remodeling  
- Heart failure (HF) with RV dysfunction  
- Cardiovascular mortality  
- Structural heart lesions (tricuspid valve dysplasia, Ebstein‑like anomaly, VSD, LVOT obstruction)  
- Atrial septal defects (ASD)  
- Ventricular septal defect (VSD)  
- Congenital valve dysplasia  
- Cardiovascular magnetic resonance (CMR)  
- Computed tomography (CT)  
- Transthoracic echocardiography (TTE)  
- Electrocardiogram (ECG)  
- Ambulatory rhythm monitoring  
- Cardiac pacing (physiological pacing, CRT, conduction‑system pacing)  
- Global‑dose management therapy (GDMT) for heart failure  
- Atrial–ventricular conduction system  
- Atrial switch operation  
- Arterial switch operation  
- Physiological repair (surgical or transcatheter)  
- Cardiopulmonary exercise testing (CPET)  
- Biomarker assay (NT‑proBNP)  
- ACHD (adult congenital heart disease)  
- Cardiac imaging  
- Systemic ventricular volume measurement  
- Rhythm abnormalities  
- Exercise training  
- Vascular remodeling  

These are the core heart‑disease–related terms and concepts extracted from the guideline text.

Page 85 Extracted Terms:
- Atrioventricular block  
- Atrial arrhythmias  
- Biatrial remodeling  
- Cardiac pacing (including LV pacing, CRT, conduction‑system pacing)  
- Cardiac electrophysiology evaluation (ambulatory rhythm monitoring)  
- Cardiac valve disease (tricuspid valve dysplasia, mitral‑like valve anomalies)  
- Cardiac valve replacement/repair (mechanical prosthesis, bioprosthesis)  
- Cardiac valve surgery (tricuspid valve surgery, valve replacement)  
- Cardiac imaging (trans‑thoracic echocardiography, 2‑D Doppler, speckle tracking, CMR, CT)  
- Chronic heart failure symptoms  
- Congenital corrected transposition of the great arteries (CCTGA)  
- Coronary artery relationship to heart structures (anatomical assessment)  
- Diagnostic monitoring (electrophysiologist’s evaluation, ambulatory rhythm monitoring)  
- End‑organ dysfunction (right‑ventricular systolic dysfunction, left‑ventricular systolic dysfunction)  
- Ejection fraction (right‑ventricular, left‑ventricular)  
- Electro‑cardiographic abnormalities (high‑grade atrioventricular block)  
- Generalized ventricular dysfunction (progressive systemic RV dysfunction)  
- Heart failure management (GDMT, angiotensin‑receptor neprilysin inhibitor)  
- Hemodynamic evaluation (LVOT stenosis – valvular and subvalvular)  
- Hemodynamic burden (chronic heart failure, RV dysfunction)  
- Impaired chronotropic response (chronotropic incompetence)  
- Imaging frequency guidelines (CMR imaging every 1–5 years)  
- Interventional therapy (surgical or transcatheter LVOT stenosis relief)  
- Long‑term outcomes (mechanical prosthesis durability, valve repair durability)  
- Management of anticoagulation (vitamin K antagonist)  
- Advanced heart failure therapies (intra‑pump or transplant referral)  
- Neurohormonal activation (targeted by neprilysin inhibitor)  
- Structural lesion (LVOT stenosis, tricuspid regurgitation)  
- Systemic ventricular dysfunction (post‑pacing, post‑surgery)  
- Symptom‑driven pacing indications (symptomatic bradycardia, heart failure symptoms)  
- Systemic tricuspid regurgitation severity (mild vs. severe, progressive disease)  
- Ventricular systolic dysfunction (moderate vs. severe, residual dysfunction post‑repair)

Page 86 Extracted Terms:
**Key Terms Related to Heart Disease**

- LVOT stenosis  
- LVOT obstruction  
- Tricuspid regurgitation  
- Ventricular septal geometry  
- Truncus arteriosus  
- Cyanotic cardiac defect  
- Pulmonary hypertension  
- Pulmonary vascular obstructive disease  
- Pulmonary arterial trunk  
- VSD (ventricular septal defect)  
- VSD closure  
- Neoaortic insufficiency  
- Neoaortic dilation  
- Double‑outlet right ventricle (DORV)  
- Mitral‑aortic discontinuity  
- Tetralogy of Fallot (TOF)  
- d‑Transposition of the great arteries (d‑TGA)  
- Rastelli repair  
- Left ventricle‑to‑aorta baffle  
- RV‑to‑PA conduit  
- Arterial switch operation  
- Fontan palliation  
- Single‑ventricle physiology  
- Hypoplastic right or left ventricle  
- Atrial isomerism  
- AVSD (atrioventricular septal defect)  
- Straddling atrioventricular valves  
- Major pulmonary artery anomalies  
- Reintervention (RV‑to‑PA reoperation)  
- Reoperation for LVOT obstruction  
- Patch leaks (VSD repair)  
- ACHD (adult congenital heart disease)  
- Electocardiogram  
- Transthoracic echocardiogram  
- Routine follow‑up intervals (physical, electrocardiogram, echocardiogram)

Page 87 Extracted Terms:
- Fontan circulation  
- single‑ventricle physiology  
- Fontan palliation  
- Fontan circulatory failure  
- heart failure  
- heart transplantation  
- Fontan‑associated liver disease (FALD)  
- hepatocellular carcinoma  
- liver fibrosis / cirrhosis  
- hepatic testing  
- portal hypertension  
- liver biopsy  
- cardiac catheterization  
- atrial tachyarrhythmias  
- atrial flutter  
- atrial fibrillation  
- supraventricular tachycardia  
- thrombus  
- thromboembolism  
- Fontan‑pathway thrombosis  
- pulmonary vasculature  
- CT angiography  
- MR imaging  
- transesophageal echocardiography  
- hypoxemia  
- systemic ventricular overload  
- aortopulmonary collaterals  
- pulmonary vasodilators  
- pulmonary hypertension  
- ventricular pacing  
- pacemaker implantation  
- atrioventricular block  
- exercise program  
- cardiac rehabilitation  
- catheter ablation  
- Fontan stenosis  
- Fontan pressure  
- Fontan conversion surgery  
- transplant‑free survival  
- anticoagulation therapy  
- aspirin therapy  
- multidisciplinary transplant committee  
- non‑cardiac organ dysfunction  
- functional capacity improvement  
- heart‑related morbidity and mortality

Page 88 Extracted Terms:
- Fontan circulation  
- Fontan procedure  
- Fontan palliation  
- Fontan circulatory failure  
- Single‑ventricle congenital heart disease  
- Systemic venous hypertension  
- Low cardiac output  
- Multi‑system disease  
- Liver cirrhosis  
- Hepatocellular carcinoma  
- Hepatic screening  
- Multidisciplinary team  
- ACHD (adult congenital heart disease) cardiologist  
- Electrocardiogram  
- Transthoracic echocardiogram  
- Cardiovascular magnetic resonance (CMR) imaging  
- Cardiac transplantation  
- Cardiac failure/heart failure  
- Advanced cardiac therapies  
- Arrhythmia  
- Thrombo‑prophylaxis  
- Structured exercise program  
- Catheter‑based interventions  
- Organ dysfunction (renal, hepatic, lymphatic)  
- Ventricular dysfunction  
- Transplant listing and timing  
- Multiorgan dysfunction  
- Obesity, social obstacles, substance use (barriers to transplant)

Page 89 Extracted Terms:
- Fontan circulation  
- Fontan pathway  
- Single‑ventricle  
- Hemodynamic assessment  
- Pulmonary circulation  
- Pulmonary pressures  
- Ventricular pressures  
- Systemic vascular resistance  
- Pulmonary vascular resistance  
- Atrial arrhythmias  
- Atrial tachyarrhythmias  
- Tachyarrhythmias  
- Ventricular dysfunction  
- Valvular disease  
- Outflow tract obstruction  
- Thrombotic complications  
- Endothelial dysfunction  
- Venous stasis  
- Clotting mechanisms  
- Hepatic dysfunction (Fontan‑associated)  
- Stroke  
- Neurocognitive decline  
- Arteriovenous malformations  
- Veno‑venous collaterals  
- Aortopulmonary collaterals  
- Shunting  
- Cardiac CT angiography  
- Cardiac MRI (CMR)  
- Transthoracic echocardiography  
- Transesophageal echocardiography  
- Single‑ventricle congenital heart disease  
- Fontan completion  
- Fontan revision  
- Fontan circulatory failure  
- Cardiac function  
- Cardiopulmonary assessment  
- Pulmonary hypertension  
- Structural heart disease  
- Hemodynamic abnormalities  
- Congenital heart disease  
- Cardiac imaging  
- Cardiac hemodynamics

Page 90 Extracted Terms:
**Key heart‑disease related terms extracted from the guideline text**

- Fontan circulation
- Fontan-associated thrombus
- Fontan-associated liver disease (FALD)
- Fontan circulatory failure
- Thrombocytopenia
- Erythrocytosis
- Lymphopenia
- Chronic hypoxemia
- Protein‑losing enteropathy
- NT‑proBNP
- Albumin
- 24‑hour stool α‑1 antitrypsin clearance
- Iron studies (serum iron, total iron‑binding capacity, ferritin)
- Fontan‑related portal hypertension
- Combined heart–liver transplantation
- Liver fibrosis (assessment via biopsy)
- Trans‑esophageal echocardiography (TEE)
- CT angiography
- Cardiac magnetic resonance (CMR)
- Sustained atrial flutter/fibrillation (>30 s)
- Thromboembolic disease
- Cerebrovascular accident (stroke)
- Atriopulmonary Fontan
- Anticoagulation (warfarin, non‑vitamin K oral anticoagulants)
- Antithrombotic prophylaxis
- Antiplatelet agents
- Bleeding contraindications
- Right‑to‑left shunting
- Kawashima procedure
- Transvenous pacemaker system
- Ventricular pacing
- Sinus node dysfunction
- Loss of atrial rhythm
- Chronotropic incompetence
- Tachy‑brady syndromes
- Bradycardia
- Functional status (decreased)
- Ventricular dysfunction
- Pulmonary venous flow reversal
- Adverse outcomes
- Hemodynamic alterations

These terms capture the diseases, complications, diagnostic markers, imaging modalities, and therapeutic strategies highlighted in the guideline.

Page 91 Extracted Terms:
- Fontan circulation  
- Atrioventricular valve function  
- Ventricular relaxation  
- Sinus node dysfunction  
- Electrophysiologist  
- Device therapy (permanent device)  
- Lead placement  
- Atrial pacing  
- Ventricular pacing  
- Atrial arrhythmias  
- Atrial flutter  
- Intra‑atrial re‑entrant tachycardia  
- Atrial fibrillation  
- Acute cardioversion  
- Ventricular dysfunction  
- Fontan circulatory failure  
- Antiarrhythmic medication  
- Thrombosis risk (Fontan population)  
- Transesophageal echocardiography  
- Anticoagulation (post‑cardioversion)  
- Heart transplantation  
- Cardiac transplantation in adult congenital heart disease (ACHD)  
- Multidisciplinary transplant team  
- ACHD (adult congenital heart disease) specialists  
- Heart failure/transplantation team  
- Congenital heart disease surgery  
- Transplant surgery  
- Cardiac imaging  
- Hepatology (transplant hepatology)  
- Psychiatry  
- Combined heart‑liver transplantation  
- Fontan‑associated liver disease (FALD)  
- Portal hypertension  
- Ascites  
- Varices  
- Splenomegaly  
- Epicardial apical site pacing  
- Ventricular synchrony  
- Exercise training (for Fontan adults)  
- Peak VO₂  
- Quality of life (cardiac context)  
- Skeletal muscle mass  
- Adiposity  
- Resistance training  
- Catheter ablation (atrial arrhythmias)  
- Atrial arrhythmia burden  
- Intra‑atrial re‑entrant tachycardia (Scar‑mediated)  
- Focal atrial tachycardias  
- Antiarrhythmic medical therapy (general)  
- Pacing (general term for cardiac pacing)

Page 92 Extracted Terms:
Fontan circulation  
Fontan pathway stenosis  
Fontan pathway conduit (extracardiac conduit)  
Fontan pressure  
Fontan obstruction  
Fontan conversion (total cavopulmonary Fontan)  
Aortopulmonary collaterals  
Pulmonary vasodilators  
Pulmonary vascular resistance (PVR)  
Ventricular preload  
Exercise performance (anaerobic threshold)  
Fenestration‑associated liver disease (FALD)  
Atrial arrhythmias (recurrent atrial arrhythmias)  
Atrial scarring  
Conduction system injury  
Electrophysiology ablation  
Stenting of Fontan pathway  
Ventricular end‑diastolic pressure  
Atrial‑ventricular valve dysfunction  
Common atrioventricular valve  
Morphologic tricuspid valve  
Protein‑losing enteropathy  
Hypoplastic left heart syndrome (HLHS)  
Norwood repair (HLHS/Norwood)  
3‑dimensional imaging of the neoaorta  
Transplantation (cardiac transplantation)  
Multidisciplinary cardiac surgical procedures (non‑transplant)  
Atrial maze procedure (modified Maze)  
Venous hypertension (elevated Fontan pressure)  
Pulmonary artery pressure  
Catheterization in adults with Fontan circulation  
Ventricular enlargement  
End‑diastolic pressure  
Aortic‑pulmonary collaterals (aortopulmonary collaterals)  
Pulmonary artery (PA)  
Cardiac output  
Conventional catheter ablation.

Page 93 Extracted Terms:
**Key Heart‑Disease Related Terms Extracted**

- HLHS (Hypoplastic Left Heart Syndrome)  
- Single‑ventricle congenital heart disease  
- Left ventricle  
- Aortic valve  
- Ascending aorta  
- Fontan physiology  
- Fontan failure  
- Norwood repair (stage 1)  
- Distal main pulmonary artery (PA)  
- Hypoplastic aorta  
- Pulmonary stump  
- Blalock‑Taussig‑Thomas shunt  
- RV‑to‑PA shunt  
- Neoaorta  
- Neoaortic dilation  
- Neoaortic obstruction  
- Neoaortic‑root pathology  
- Hypoplastic aortic root  
- Coronary ischemia  
- Ventricular dysfunction  
- Atrioventricular valve dysfunction  
- Neurocognitive dysfunction  
- Periodic imaging  
- MR angiography  
- CT angiography  
- Echocardiography  
- Cardiac transplantation  
- Eisenmenger syndrome  
- Right‑to‑left shunting  
- Pulmonary arterial hypertension (PAH)  
- Invasive hemodynamic assessment  
- PAH‑directed therapy  
- Endothelin receptor antagonist  
- Phosphodiesterase‑5 inhibitor  
- Prostacyclin therapy (inhaled/subcutaneous)  
- Anticoagulation therapy  
- Thromboembolic complications  
- Pulmonary arterial thrombosis  
- Atrial arrhythmias  
- Intracardiac shunt  
- Permanent pacing  
- Implantable cardioverter–defibrillator (ICD)  
- Endocardial leads  
- Cyanosis  
- Hyperviscosity  
- Iron supplementation  
- 6‑minute walk distance  
- Tricuspid annular plane systolic excursion (TAPSE)  
- NT‑proBNP  
- World Health Organization (WHO) functional class  
- Left ventricular ejection fraction (LV EF)  
- High bleeding risk  
- Perioperative risk  
- Morbidity and mortality  
- Clinical surveillance protocol  
- Advanced cardiac therapies  

These terms capture the principal diseases, anatomical and physiological concepts, diagnostic methods, therapeutic approaches, and risk factors discussed in the guideline text.

Page 94 Extracted Terms:
**Key terms related to heart disease**

- Eisenmenger syndrome  
- Pulmonary arterial hypertension (PAH)  
- Congenital heart disease (CHD) / ACHD  
- Left‑to‑right shunt defects  
- Right‑to‑left shunt / bidirectional shunting  
- High pulmonary vascular resistance (PVR)  
- Chronic cyanosis  
- Diastolic dysfunction  
- Systolic dysfunction  
- Arrhythmias  
- Sudden cardiac death (SCD)  
- Down syndrome  
- Obstructive sleep apnea  
- Thyroid dysfunction  
- 6‑minute walk distance (6MWD)  
- Supplemental oxygen therapy  
- High‑altitude exposure  
- Pregnancy in CHD patients  
- Nephrotoxic exposure  
- Mechanical circulatory support  
- Pulmonary circulatory support  
- Lung transplantation (with cardiac repair)  
- Heart‑lung transplantation  
- Endothelin‑receptor antagonists  
- Bosentan  
- Macitentan  
- Phosphodiesterase‑5 (PDE5) inhibitors  
- Sildenafil (example PDE5 inhibitor)  
- Soluble guanylate cyclase stimulator (riociguat)  
- Prostacyclin analogs / receptor agonists  
- Inhaled iloprost  
- Selexipag (oral prostacyclin receptor agonist)  
- Activin signaling inhibitor (sotatercept)  
- B‑type natriuretic peptide (BNP)  
- N‑terminal proBNP (NT‑proBNP)  
- World Health Organization (WHO) functional class  
- Systemic vascular resistance (SVR)  
- Risk‑assessment tools (e.g., 6MWD, hemodynamic parameters)  

These terms encompass diseases, clinical features, risk factors, diagnostic markers, and therapeutic modalities relevant to heart disease, particularly in the context of Eisenmenger syndrome and associated congenital heart conditions.

Page 95 Extracted Terms:
- Eisenmenger syndrome  
- Pulmonary arterial hypertension (PAH)  
- Bidirectional shunting  
- Large septal defects  
- Pulmonary vascular resistance (PVR)  
- Postcapillary pulmonary hypertension  
- Valvular regurgitant lesion  
- Right‑ventricular (RV) pressure overload  
- Mechanical circulatory support (MCS)  
- Transplantation (cardiac/heart‑lung)  
- Brain natriuretic peptide (BNP)  
- N‑terminal pro‑BNP (NT‑proBNP)  
- Six‑minute walk distance  
- Functional class assessment  
- Risk stratification models  
- Down syndrome  
- Pretricuspid shunt  
- Age (advanced patient age)  
- Hypoxemia  
- Glomerular filtration rate (GFR)  
- Echocardiographic indices of RV dysfunction  
- Systemic vascular resistance  
- Volume overload  
- Univentricular hearts  
- Pregnancy in PAH  
- Right‑to‑left shunting  
- Spontaneous miscarriages  
- PAH crises (post‑partum)  
- Thromboembolic events  
- Paradoxical embolism  
- World Health Organization (WHO) class IV  
- Maternal and fetal morbidity/mortality  
- Multidisciplinary cardio‑obstetrics team  
- Adult congenital heart disease (ACHD) specialists  
- Pulmonary hypertension specialists  
- Obstetric anesthesia  
- Endothelin receptor antagonist therapy  
- Macitentan (endothelin‑1 receptor antagonist)  
- Bosentan (endothelin receptor antagonist)  
- Phosphodiesterase‑5 inhibitors (PDE‑5i)  
- Electrocardiogram (ECG)  
- Transthoracic echocardiogram (TTE)  
- ACHD cardiologist  

(This list captures the key heart‑disease terms and concepts mentioned in the guideline excerpt.)

Page 96 Extracted Terms:
- Eisenmenger syndrome  
- Pulmonary arterial hypertension (PAH)  
- Adult congenital heart disease (ACHD)  
- Systemic vascular resistance  
- Oxygen saturations  
- Phosphodiesterase‑5 inhibitor therapy  
- 6‑minute walk distance  
- Hemodynamics  
- Adult with Eisenmenger syndrome clinical characteristics  
- Upfront combination PAH therapy  
- Monotherapy in PAH  
- Sildenafil (PDE5 inhibitor)  
- Ambrisentan (endothelin receptor antagonist)  
- New York Heart Association (NYHA) functional class  
- Pulmonary pressures (mean pulmonary artery pressure, systolic, diastolic)  
- NT‑proBNP levels  
- Pulmonary vascular resistance (PVR)  
- Qp:Qs (pulmonary to systemic flow ratio)  
- Triple vasodilator therapy  
- Subcutaneous treprostinil  
- Inhaled iloprost  
- Oral prostacyclin analog selexipag  
- Intravenous prostacyclin  
- Paradoxical embolization  
- Arrhythmias (atrial, ventricular)  
- Morbidity and mortality in Eisenmenger syndrome  
- Hemodynamic stability  
- Cardiac anesthesia support  
- Cardioversion for atrial arrhythmias  
- Mild‑to‑moderate intensity exercise  
- World Health Organization (WHO) functional class  
- Home‑based exercise training program  
- Competitive sports and extreme isometric exercise (to be avoided)  
- PAH‑directed medications  
- Prostacyclin therapy (inhaled, subcutaneous, intravenous)  
- Small prospective trial of inhaled prostacyclin in Eisenmenger patients with normal LV function  
- Right ventricular (RV) function  
- Left ventricular (LV) function  
- Clinical trials of PAH‑directed therapy in Eisenmenger syndrome  
- Riociguat (sGC stimulator)  
- Thrombosis in Eisenmenger syndrome  
- Dilated pulmonary arteries (PAs)  
- Dilated or dysfunctional cardiac chambers  
- Intracardiac prosthetic materials (pacemaker leads)  
- Laminated (in‑situ) thrombi  
- Aneurysmal pulmonary arteries  
- Cerebrovascular events (stroke, silent infarcts)  
- Systemic arterial and venous thromboembolic events  
- Systemic anticoagulation treatment  
- Pulmonary hypertension management strategies.

Page 97 Extracted Terms:
- Atrial fibrillation  
- Atrial flutter  
- CHA₂DS₂‑VASc score  
- HAS‑BLED score  
- Anticoagulation  
- Vitamin K antagonists  
- Low‑molecular‑weight heparin  
- Direct oral anticoagulants  
- Eisenmenger syndrome  
- Bleeding risk (↓ factor II, V, VII, IX, X, ↓ von Willebrand factor)  
- Hemoptysis  
- Intrapulmonary hemorrhage  
- Bronchial artery erosion  
- Pulmonary vascular disease  
- Bidirectional shunt  
- Right‑ventricular (RV) strain  
- Intracardiac shunts  
- Transvenous pacemaker leads  
- Epicardial pacemaker leads  
- Subcutaneous implantable cardioverter‑defibrillator (ICD)  
- Systemic thromboembolism  
- Coronary artery anomalies  
- Anomalous aortic origin of a coronary artery (AAOCA)  
- Coronary CT angiography  
- MR angiography  
- Myocardial ischemia attributable to AAOCA  
- Surgical repair (coronary revascularization)  
- High‑risk anatomy (ostial/proximal stenosis, slit‑like orifice, acute angle of takeoff, intramural course)  
- Sudden cardiac death (SCD)  
- Coronary fistula

Page 98 Extracted Terms:
- Anomalous Aortic Origin of the Coronary Artery (AAOCA)  
- Coronary CT angiography  
- Cardiac Magnetic Resonance (CMR) angiography  
- Invasive coronary angiography  
- Intravascular ultrasound (IVUS)  
- Fractional flow reserve (FFR)  
- Coronary artery stenosis  
- Cardiovascular risk stratification  
- Shared decision‑making  
- Serial cardiac imaging  
- Exercise stress testing  
- Coronary artery disease (CAD)  
- Coronary artery bypass graft (CABG)  
- Coronary unroofing (surgery)  
- Osteoplasty (surgical technique)  
- Coronary reimplantation (surgical technique)  
- Pulmonary translocation (surgical technique)  
- Intramural coronary course  
- Fibrosis imaging (via CMR)  
- Shunt assessment  
- Hemodynamic evaluation (for shunts)

Page 99 Extracted Terms:
- Anomalous aortic origin of a coronary artery (AAOCA)  
- Anomalous right coronary artery (ARCA)  
- Anomalous left coronary artery (ALCA)  
- Anomalous left coronary artery arising from the pulmonary artery (ALCAPA)  
- Anomalous right coronary artery arising from the pulmonary artery (ARCAPA)  
- Sudden cardiac death (SCD)  
- Myocardial ischemia / ischemic changes  
- Wall‑motion abnormalities  
- Fractional flow reserve (FFR)  
- Coronary unroofing  
- Osteoplasty (coronary)  
- Coronary reimplantation  
- Pulmonary translocation  
- Coronary artery bypass graft (CABG)  
- Ventricular arrhythmias  
- Exercise stress testing  
- Dobutamine stress testing  
- Stress electrocardiogram (ECG)  
- Echocardiography (transthoracic, Doppler)  
- Nuclear imaging (myocardial perfusion)  
- Cardiac magnetic resonance (CMR) imaging  
- Cardiac function (ejection fraction, systolic function)  
- Cardiac dysfunction  
- Risk stratification  
- Physiological impact / assessment  
- Intramural coronary course  
- Hypoplasia of the proximal segment  
- Ostial stenosis  
- Slit‑like orifice  
- Acute angle of takeoff  
- High‑risk features  
- Shared decision‑making  
- Watchful waiting  
- Adult congenital heart disease (ACHD)  
- Computed tomography (CT) angiography  
- Magnetic resonance (MR) angiography  
- Electrocardiogram (ECG) follow‑up  
- Transthoracic echocardiogram follow‑up  

Page 100 Extracted Terms:
- Anomalous right coronary artery (ARCA) from the pulmonary artery  
- Anomalous left coronary artery (ALCA) from the pulmonary artery  
- Coronary artery fistula  
- Coronary steal phenomenon  
- Coronary artery bypass grafting (CABG)  
- Takeuchi repair  
- Coronary artery reimplantation  
- Ligation/closure of coronary artery at the pulmonary artery level  
- Ventricular dysfunction  
- Myocardial ischemia  
- Angina pectoris  
- Dyspnea  
- Heart failure  
- Myocardial infarction  
- Vascular ring  
- Pulmonary artery sling  
- Vascular ring repair  
- Pulmonary artery sling repair  
- Cross‑sectional imaging of aortic arch and pulmonary arteries  
- Airway compression symptoms (e.g., stridor, wheezing)  
- Esophageal compression symptoms (e.g., dysphagia)  
- Congenital heart disease (CHD)  
- Ventricular septal defect (VSD) as a common comorbidity  
- Right internal mammary artery (RIMA) graft  
- Left internal mammary artery (LIMA) graft  
- Coronary artery interposition graft  
- Sudden cardiac death (SCD) related to coronary anomalies  
- Coronary fistula closure (surgical or catheter‑based)

Page 101 Extracted Terms:
**Key Heart‑Disease Terms Extracted**

1. Adults with Congenital Heart Disease (ACHD)  
2. TOF (Tetralogy of Fallot)  
3. Vascular ring  
4. Pulmonary artery (PA) sling  
5. Pulmonary valve replacement  
6. Pulmonary stenosis  
7. Pulmonary regurgitation  
8. RV‑to‑PA conduit stenosis  
9. RV‑to‑PA conduit regurgitation  
10. Systemic right ventricle  
11. Pacing strategies  
12. Arrhythmia strategies  
13. Endocarditis risk in prosthetic valves (transcatheter or surgical)  
14. Transcatheter or surgical prosthetic valves  
15. Cardiac rehabilitation  
16. Exercise testing for clinical outcomes  
17. Genetic screening for ACHD  
18. Neurocognitive screening in ACHD  
19. Mental‑health screening in ACHD clinics  
20. Hormone replacement therapy in ACHD patients  
21. Gender‑affirming therapies in ACHD  
22. Pulmonary function testing  
23. Barium swallow testing  
24. Cardiac magnetic resonance imaging (CMR)  
25. Computed tomography (CT) angiography  
26. Tracheal compression  
27. Tracheomalacia  
28. Post‑operative imaging for vascular ring/PA sling  
29. Multidisciplinary subspecialties (pulmonary medicine, gastroenterology)  
30. Surgical repair of vascular ring/PA sling  
31. Asymptomatic vs symptomatic vascular ring/PA sling  
32. Vascular ring anatomical classifications (complete, incomplete, double aortic arch, etc.)

Page 102 Extracted Terms:
- Adult Congenital Heart Disease (ACHD)  
- Artificial Intelligence–ECG (AI‑ECG)  
- Guideline‑Directed Medical Therapy (GDMT)  
- Failing Right Ventricle  
- Failing Left Ventricle  
- Heart Failure  
- Heart Transplantation  
- Heart‑Versus‑Liver Transplantation (in Fontan patients)  
- Cardiac Transplantation Criteria (Fontan circulation)  
- Sudden Cardiac Death (SCD)  
- Primary‑Prevention Implantable Cardioverter‑Defibrillator (ICD)  
- Shunt Lesions (e.g., ASD, VSD, patent ductus)  
- Shunt Repair / Closure  
- Pulmonary Arterial Hypertension (PAH)  
- Coarctation of the Aorta (COA)  
- Resting, Exercise, and Ambulatory Hypertension  
- Exercise‑Induced Hypertension  
- Re‑Coarctation  
- Ebstein Anomaly  
- Glenn Shunt (Bidirectional Cavopulmonary Anastomosis)  
- Tetralogy of Fallot (TOF)  
- Pulmonary Valve Replacement (in TOF)  
- Left Ventricular (LV) Dysfunction (post‑TOF)  
- Systemic Right Ventricle  
- Tricuspid Valve Replacement (systemic right ventricle)  
- Cardiac Resynchronization Therapy (CRT)  
- Congenitally Corrected Transposition of the Great Arteries (CCTGA)  
- Ventricular Septal Defect (VSD)  
- Double‑Switch Operation  
- Arterial Switch Operation (d‑TGA)  
- Coronary Disease, Ostial Compression, Ischemia  
- Aortic Root Dilation  
- Antiplatelet Therapy  
- Anticoagulation Therapy  
- Pulmonary Vasodilators  
- Fontan‑Associated Liver Disease (FALD)  
- Protein‑Losing Enteropathy (PLE)  
- Lymphatic Abnormalities (Fontan)  
- Hypoplastic Left Heart Syndrome (HLHS)  
- Single‑Ventricle Physiology  
- Fontan Circulation  

(Each entry represents a key heart‑disease term or concept from the guideline text.)

Page 103 Extracted Terms:
- Double‑chamber right ventricle  
- Subaortic obstruction  
- Aortic dilation  
- Tetralogy of Fallot (TOF)  
- Dextrotransposition of the great arteries (d‑TGA)  
- Arterial switch operation  
- Single‑ventricle physiology  
- Fontan circulation  
- Ross procedure  
- Coronary arteries  
- Premature coronary artery disease  
- Obstruction (clinical threshold for intervention)  
- Stenosis (clinical threshold for intervention)  
- Congenital heart disease (CHD)  
- Intervention criteria in congenital heart conditions  
- Coronary artery disease (CAD) for congenital heart disease patients  

Page 104 Extracted Terms:
- Adult Congenital Heart Disease  
- Congenital Heart Disease  
- Valvular Heart Disease  
- Aortic Disease  
- Coronary Artery Disease  
- Chronic Coronary Disease  
- Heart Failure  
- Atrial Fibrillation  
- Arrhythmias  
- Tetralogy of Fallot (repaired)  
- Heart‑Kidney Transplantation  
- Heart‑Liver Transplantation  
- Multimodality Cardiovascular Imaging  
- Transition to Adulthood (for congenital heart disease)  
- Genetic Basis of Congenital Heart Disease  
- Psychological Outcomes in Congenital Heart Disease  
- Neurodevelopmental Outcomes in Congenital Heart Disease  
- Cardiac Nomenclature (International Pediatric and Congenital Cardiac Code)  
- Cardiovascular Catheterisation (Procedural and Complication Nomenclature)  
- Cardiovascular Complications (in interventional cardiology)

Page 105 Extracted Terms:
- Adult congenital heart disease (ACHD)  
- Congenital heart disease (CHD)  
- Anatomic‑physiologic classification system  
- Risk stratification / mortality prediction models  
- ACHD mortality score  
- Ebstein anomaly  
- Tetralogy of Fallot  
- Fontan procedure / Fontan circulation  
- Valvular heart disease (VHD)  
- Heart failure (HF)  
- Pulmonary hypertension (PH)  
- Infective endocarditis (IE)  
- Arrhythmia burden  
- Implantable cardioverter‑defibrillator (ICD)  
- Cardio‑pulmonary exercise testing (CPET)  
- N‑terminal pro‑brain natriuretic peptide (NT‑proBNP)  
- N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP)  
- Troponin‑T  
- Growth‑differentiation factor‑15 (GDF‑15)  
- Peak oxygen uptake (VO₂ peak)  
- Ventilatory efficiency (VE/VCO₂ slope)  
- QRS duration  
- Hospitalization trends & health‑resource utilization  
- Transition readiness & education programs  
- Barriers to care & access to specialty services  
- Functional indices (e.g., New York Heart Association class)  
- Clinical outcomes & morbidity‑mortality predictors

Page 106 Extracted Terms:
**Key Terms Related to Heart Disease**

1. Congenital heart disease  
2. Adult congenital heart disease (ACHD)  
3. Transition (care/education)  
4. Gaps in care  
5. Morbidity  
6. Mortality  
7. Specialist care  
8. Telemedicine / digital health technology  
9. Social determinants of health  
10. Distance to care / travel distance  
11. Rural dwelling status / urban‑rural disparities  
12. Access to care  
13. Delivery of care  
14. Knowledge of lifelong cardiac care  
15. Transition education programs (e.g., STEPSTONES, TRANSITION‑CHD)  
16. SCAI position statement on ACHD interventional training  
17. ESC guidelines for ACHD management  
18. AHA/ACC guideline for ACHD  
19. Catheter ablation in ACHD  
20. Heart transplantation in ACHD  
21. Clinical trials / randomized controlled trials  
22. Clinical statements / scientific statements  
23. Risk factors for loss to follow‑up  
24. Quality of care  
25. Policy impact on mortality and outcomes  
26. Patient education and readiness  
27. Healthcare transition for youth with heart disease  

(Note: Each term represents a concept, intervention, outcome, or structural factor repeatedly mentioned in the provided guideline text.)

Page 107 Extracted Terms:
**Key heart‑disease–related terms extracted from the text**

- Adult congenital heart disease (ACHD)  
- Congenital heart disease (CHD)  
- Fontan physiology / Fontan palliation / Fontan circulation  
- Eisenmenger syndrome  
- Atrial septal defect (ASD)  
- Perioperative morbidity and mortality  
- Perioperative outcomes  
- Perioperative cardio‑vascular evaluation and management  
- Perioperative considerations/management for non‑cardiac surgery  
- Non‑cardiac surgery  
- Perioperative events  
- Anesthesia (and anesthetic management)  
- Frailty in ACHD  
- Cognitive function / neurocognitive impairment / neurocognitive dysfunction  
- Neurodevelopmental outcomes  
- Depression in ACHD  
- Anxiety in ACHD  
- Post‑traumatic stress disorder (PTSD) in ACHD  
- Mental health screening (PHQ‑4, etc.)  
- Health‑care utilization in ACHD  
- Stroke risk (ischemic stroke) in the peri‑operative period  
- Clinical practice guidelines (ACC/AHA Task Force)  
- Clinical statements & scientific statements (American Heart Association)  
- Clinical trial / randomized controlled trial (RCT)  
- Prospective and retrospective cohort studies on ACHD outcomes  

These terms capture the primary concepts relating to heart disease and its peri‑operative, anesthetic, and psychosocial aspects that appear throughout the document.

Page 108 Extracted Terms:
**Key heart‑disease related terms extracted from the text**

- Congenital heart disease (CHD)  
- Cyanotic congenital heart disease  
- Eisenmenger syndrome  
- Unoperated single ventricle  
- Heart failure  
- Cardiac resynchronization therapy (CRT)  
- Single‑ventricle repair  
- Cardiac surgery / cardiac operative procedures  
- Perioperative mortality risk  
- Cyanosis management  
- Iron deficiency therapy  
- Exercise capacity / exercise intolerance  
- Quality of life  
- Cerebrovascular events (stroke)  
- Brain abscess  
- Stroke risk in cyanotic disease  
- Pregnancy outcomes in women with heart disease  
- Hormonal contraception & risk of venous thromboembolism  
- Pheochromocytoma / paraganglioma  
- Hyperuricemia  
- Serum uric acid in Eisenmenger syndrome  
- Oxygen therapy effect on exercise performance  
- Hemoglobin & oxygen saturation dynamics  
- Blood viscosity  
- Iron metabolism & homocysteine levels  
- Hematocrit & haemostasis  
- Platelet microparticles  
- Thrombogenesis / hypercoagulability  
- Pulmonary artery thrombosis  
- Anticoagulation in Eisenmenger syndrome  
- Long‑term survival / prognosis  
- Pulmonary arterial hypertension (PAH)  
- Lung function & gas exchange in PAH/Eisenmenger  
- Pulmonary hypertension in CHD  
- Neurodevelopmental evaluation in CHD  
- Restrictive lung disease in CHD  
- Abnormal lung function in adult CHD  
- Cardiac catheter intervention safety  
- Operative volume & surgical learning curve  
- Reoperative cardiac surgery outcomes  
- Clinical management guidelines for adult congenital heart disease  
- Practice patterns for adult congenital heart disease management  

These terms encapsulate the clinical concepts, patient populations, interventions, complications, and outcomes addressed throughout the cited guidelines and literature.

Page 109 Extracted Terms:
- Congenital heart disease (CHD)  
- Adult congenital heart disease (ACHD)  
- Heart failure (HF)  
- Universal definition and classification of heart failure  
- Cardiac resynchronisation therapy (CRT)  
- Cardiac resynchronisation therapy (CRT‑D)  
- Implantable cardioverter‑defibrillator (ICD)  
- Implantable cardioverter‑defibrillator (ICD) in ACHD  
- Sodium‑glucose cotransporter‑2 (SGLT‑2) inhibitors in ACHD  
- Angiotensin‑receptor neprilysin inhibitor (ARNI) in ACHD  
- Sacubitril/valsartan (ARNI) in adult complex CHD  
- Ventricular assist device (VAD) / durable VAD  
- Mechanical circulatory support (MCS)  
- Mechanical circulatory support (MCS) in ACHD (INTERMACS, UNOS)  
- Heart transplantation in ACHD  
- Heart–lung transplantation in ACHD  
- Combined heart–liver transplantation in the failing Fontan  
- Multi‑organ transplantation in ACHD  
- Fontan circulation / Fontan surgery  
- Fontan‑adult Brompton clinical score  
- Mustard operation (surgical correction of transposition of great arteries)  
- Transposition of the great arteries (TGA) with systemic right ventricle  
- Ebstein anomaly  
- Tetralogy of Fallot (TOF)  
- Sudden cardiac death (SCD) in ACHD  
- Ventricular arrhythmias in ACHD  
- PRospEctiVE study (PREVENTION‑ACHD)  
- PREVENTION‑ACHD acronym (ICB‑VSD)  
- Heart‑failure Society of America (HFSA) consensus  
- American Heart Association (AHA) 2022 Heart Failure Guideline  
- Cardiac‑electrophysiology guidelines for pediatric and congenital heart disease  
- European Society of Cardiology (ESC) heart‑failure definition  
- INTERMACS registry for adult CHD patients on MCS  
- German National Register for Congenital Heart Defects (GNHFD)  
- Clinical outcomes and survival metrics in ACHD  
- Post‑operative arrhythmias after Fontan operation  
- Arrhythmic risk scores in systemic right ventricle  
- Implantable cardioverter‑defibrillator shock appropriateness in repaired TOF  
- Long‑term survival, mortality, and morbidity after heart transplantation in CHD  
- Acute and chronic heart failure in congenital heart disease (ACC/AHA statement)  

(These terms capture the key entities, therapies, devices, scores, and clinical contexts discussed in the guidelines and studies.)

Page 110 Extracted Terms:
- Congenital heart disease  
- Adult congenital heart disease  
- Heart transplantation  
- Heart‑lung transplantation  
- Combined heart‑liver transplantation  
- Mechanical circulatory support  
- Ventricular assist device (VAD)  
- Continuous‑flow ventricular assist device  
- INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support)  
- Fontan circulation  
- Eisenmenger syndrome  
- Tetralogy of Fallot  
- Pulmonary atresia  
- Single ventricle (univentricular)  
- Biventricular condition  
- Heterotaxy syndrome  
- Left ventricular systolic dysfunction  
- Heart failure  
- Heart failure hospitalization  
- Peak oxygen consumption  
- Anti‑human leukocyte antigen (anti‑HLA) antibodies  
- Allograft tissue exposure  
- Allograft cryopreservation  
- Right ventricular failure (implied in Fontan context)  
- 22q11.2 deletion syndrome  
- Chromosomal abnormalities  
- Copy‑number variant / de novo mutation  

(Note: Terms are derived directly from the guideline titles, study descriptions, and clinical focuses within the provided text.)

Page 111 Extracted Terms:
- Congenital heart disease  
- Pulmonary atresia  
- Ventricular septal defect  
- Conotruncal defects  
- 22q11.2 deletion (DiGeorge syndrome)  
- Noonan syndrome  
- Williams‑Beuren syndrome  
- Down syndrome  
- Holt‑Oram syndrome  
- Klinefelter syndrome  
- Turner syndrome  
- NKX2‑5 mutation  
- QTc interval prolongation  
- Cardiac repolarization abnormalities  
- Sudden cardiac death  
- Cardiomyopathy  
- Heart failure  
- Peripartum cardiomyopathy  
- Valvular heart disease  
- Coronary artery dissection  
- Pregnancy outcomes in heart disease  
- Cardiac morbidity during pregnancy  
- Hormonal contraception cardiovascular risk  
- Cardiac risk assessment  
- Echocardiographic screening  
- Cardio‑obstetrics program  
- Multidisciplinary cardiac care  
- Reproductive health in congenital heart disease  
- Cardiac risk stratification  
- Congenital cardiovascular malformations  
- Genetic counselling for congenital heart disease  
- Cardiac phenotypic spectrum  

Page 112 Extracted Terms:
Congenital heart disease  
Congenital heart defects  
Tetralogy of Fallot  
Fontan physiology / Fontan patients  
Eisenmenger syndrome  
Transposition of the great arteries  
Ebstein anomaly  
Coarctation of the aorta  
Pulmonary arterial hypertension  
Pulmonary valve replacement  
Cardiac catheterization  
Cardiac procedures  
Cardiac surgery  
Cardiac radiation exposure  
Ionizing radiation exposure  
Heart failure  
Cardiopulmonary exercise testing  
Exercise capacity  
Exercise intolerance  
New York Heart Association (NYHA) functional class  
NT‑proBNP  
Cardiac biomarkers  
Mortality risk  
Prognosis  
Clinical outcomes  
Multidisciplinary heart team  
Pregnancy heart team  
Maternal heart disease  
Cardiovascular disease during pregnancy  
Reproductive health in congenital heart disease  
Preconception counseling  
Fertility  
Sexual health  
Assisted reproductive technology  
Contraception  
Cumulative radiation exposure  
Long‑term chromosomal damage  
Pharmacological management for exercise capacity  
Cardiac imaging parameters  
Spirometry as a predictive tool  

Page 113 Extracted Terms:
**Key heart‑disease related terms extracted from the guidelines text**

- Adult congenital heart disease  
- Eisenmenger syndrome  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary hypertension  
- Atrial septal defect (ASD)  
- Shunt lesions  
- Fontan circulation / univentricular physiology  
- Pulmonary arterial hypertension related to congenital heart disease  
- 6‑minute walk test  
- Resting oxygen saturation  
- Functional class (NYHA/WHO)  
- Cardiopulmonary capacity  
- Cardiorespiratory fitness  
- Inspiratory muscle training  
- Cardiac rehabilitation (center‑based, home‑based, virtual)  
- Exercise training (continuous, interval, home‑based, pulmonary rehab)  
- Exercise capacity  
- Functional capacity  
- B‑type natriuretic peptide (BNP)  
- C‑reactive protein (CRP)  
- Renal dysfunction (kidney disease)  
- Bosentan therapy  
- Treat‑to‑close strategy  
- Treat‑close‑treat strategy  
- Treat‑and‑repair strategy  
- Competitive sports participation guidelines for athletes with cardiovascular abnormalities  
- European Society of Cardiology / European Respiratory Society guidelines for pulmonary hypertension  
- Refined European guidelines instrument for risk prediction in PAH  
- Arrhythmias during exercise testing

These terms capture the principal diseases, diagnostic measures, therapeutic strategies, and contexts discussed in the clinical statements and guidelines.

Page 114 Extracted Terms:
Eisenmenger syndrome  
Pulmonary arterial hypertension  
Atrial septal defect  
Ventricular septal defect  
Partial anomalous pulmonary venous drainage  
Partial anomalous pulmonary venous connection  
Patent foramen ovale  
Superior sinus venosus defect  
Secundum atrial septal defect  
Tricuspid regurgitation  
Pulmonary hypertension  
Bosentan therapy  
Macitentan therapy  
Tadalafil therapy  
Iloprost therapy  
Epoprostenol therapy  
Prostaglandin therapy  
Sildenafil citrate therapy  
Selexipag therapy  
Sotatercept therapy  
Transcatheter closure  
Covered stent exclusion  
Balloon occlusion test  
Surgical repair  
ESC/ERS guideline for pulmonary hypertension  
AHA/ACC guideline for adult congenital heart disease  
CHEST guideline for pulmonary arterial hypertension  
Electrocardiography (implied by diagnostic context)  
Echocardiography (including transesophageal)  
Magnetic resonance imaging (four‑dimensional)  
Computed tomography scanning  
Hemodynamic assessment (catheterization)  
Right ventricular function evaluation  
Left ventricular diastolic dysfunction assessment  

These terms capture the key heart‑related conditions, therapies, interventions, diagnostic modalities, and guideline references present in the text.

Page 115 Extracted Terms:
- Pulmonary arterial hypertension  
- Pulmonary hypertension  
- Congenital heart disease  
- Ventricular septal defect (VSD)  
- Isolated ventricular septal defect  
- Supracristal ventricular septal defect  
- Perimembranous ventricular septal defect  
- Non‑restrictive ventricular septal defect  
- Double‑chambered right ventricle  
- Aortic regurgitation  
- Aortic cusp prolapse  
- Infective endocarditis  
- Left‑to‑right shunt  
- Right ventricular dysfunction  
- Left ventricular dysfunction  
- Pulmonary vascular resistance  
- Pulmonary hypertensive crisis  
- Transcatheter device closure  
- Surgical closure of VSD  
- Percutaneous device closure of VSD  
- Treat‑and‑repair strategy  
- Perioperative management of pulmonary hypertension  
- Sildenafil therapy for pulmonary hypertension  
- Selexipag therapy for pulmonary hypertension  
- Macitentan therapy for pulmonary hypertension  
- Inhaled nitric oxide (pre‑operative test)  
- Ventricular septal defect repair techniques (patch, valve‑patch, double‑patch)  
- Natural history of congenital ventricular septal defect  
- Long‑term outcomes of VSD repair  
- Survival of patients with congenital VSD  
- Infection prevention guidelines for infective endocarditis  
- Catheterization in congenital heart disease  
- Lung biopsy utility in congenital heart disease management  
- Clinical guidelines for infective endocarditis  
- Clinical outcomes of pulmonary arterial hypertension in congenital heart disease.

Page 116 Extracted Terms:
**Key terms related to heart disease**

- Congenital heart disease (CHD)  
- Atrioventricular (AV) septal defect (AVSD)  
  - Complete AV septal defect  
  - Partial/transition AV septal defect  
- Ventricular septal defect (VSD)  
- Pulmonary arterial hypertension (PAH)  
- Partial anomalous pulmonary venous return (PAPVR)  
- Scimitar syndrome  
- Patent ductus arteriosus (PDA)  
- Left ventricular outflow tract (LVOT) obstruction  
- Atrial septal defect (ASD)  
  - Secundum ASD  
  - Sinus venosus ASD  
  - Ostium primum ASD  
- Pulmonary hypertension (PH)  
- Left-valvar morphology (mitral)  
- Heart block (conduction disturbances)  
- Left ventricular remodeling / reverse remodeling  
- Device closure (transcatheter)  
- Surgical closure / repair of congenital lesions  
- Magnetic resonance imaging (MRI) in cardiac imaging  
- Transcatheter pulmonary arterial hypertension therapy  
- Targeted pulmonary hypertension therapy  
- Clinical practice guideline (AHA/ACC, ACC/AHA, ESC/ERS)  
- Scientific statement (American Heart Association)  
- Operability assessment in adult congenital heart disease  
- Prognostic factors for residual lesions after surgery  
- Outcomes after specialty care for PAH  
- Late results of VSD closure (30–35 years)  
- Right atrial involvement in AVSD  
- Superior QRS axis in ostium primum ASD  
- Indications for surgery based on lung biopsy in VSD/PDA with severe PH  
- Long‑term outcomes of unrepaired PAPVR with intact atrial septum  

These terms capture the principal heart‑disease concepts, conditions, interventions, and guideline references highlighted in the provided text.

Page 117 Extracted Terms:
**Key terms related to heart disease extracted from the text**

- Cor triatriatum sinister / sinistrum  
- Congenital heart disease  
- Pulmonary hypertension  
- Pulmonary vascular resistance  
- Left ventricular dysfunction  
- Patent ductus arteriosus closure (surgical & transcatheter)  
- Cardiovascular magnetic resonance  
- Surgical repair of cor triatriatum  
- Transcatheter balloon dilatation of cor triatriatum  
- Inoue balloon‑dilation method  
- Radiofrequency perforation & balloon decompression  
- Aortic dissection  
- Mitral insufficiency  
- Mitral stenosis  
- Congenital mitral stenosis (parachute mitral valve)  
- Shone complex  
- Subaortic stenosis (discrete subaortic stenosis)  
- Cardioembolic stroke  
- Thrombogenesis & arrhythmogenesis in left atrium  
- Partial anomalous pulmonary venous return  
- Ventricular inflow obstruction (pulmonary venous & systemic)  
- Atrial fibrillation in adult congenital heart disease  
- Catheter ablation for atrial fibrillation  
- Cardiopulmonary exercise testing  
- Pulmonary edema (postpartum, labor, pregnancy)  
- Maternal cor triatriatum management during pregnancy  
- Anesthetic management for cardiac surgery in pregnancy  
- Cardiopulmonary bypass in pregnancy  
- 3‑D echocardiographic‑guided surgical repair  
- 2018 AHA/ACC guideline (adults with congenital heart disease)  
- 2020 ACC/AHA guideline (valvular heart disease)  
- 2018 AHA/ACC guideline (adults with congenital heart disease)  
- 2020 ACC/AHA guidline (valvular heart disease)  
- Early‑age percutaneous balloon dilatation  
- Percutaneous balloon dilatation vs. surgical correction  

These terms capture the primary heart‑related concepts, conditions, interventions, and guideline references presented in the document.

Page 118 Extracted Terms:
**Heart‑Disease Related Terms Extracted from the Text**

1. Hypertrophic cardiomyopathy  
2. Aortic regurgitation  
3. Subaortic stenosis (including discrete subvalvular aortic stenosis)  
4. Bicuspid aortic valve  
5. Aortic aneurysm (ascending aortic aneurysm, thoracic aortic aneurysm)  
6. Aortic stenosis (including supravalvular aortic stenosis and congenital aortic valve stenosis)  
7. Transcatheter aortic valve replacement (TAVR)  
8. Balloon aortic valvuloplasty  
9. Supravalvar aortic stenosis  
10. Williams syndrome (elastin‑associated arteriopathy)  
11. Elastin arteriopathy  
12. Left ventricular remodeling  
13. Post‑operative heart failure  
14. Aortic valve dysfunction  
15. Aortic valve replacement (surgical AVR)  
16. Aortic events (e.g., dissection, rupture)  
17. Aortic disease (diagnosis & management)  
18. Congenital heart disease (adult congenital)  
19. Bicuspid vs tricuspid aortic valve outcomes  
20. Aortic dilatation / aortic root dilation  
21. Coronary artery stenosis (ostial)  
22. Coronary artery aneurysm  
23. Valvular heart disease (management)  
24. Risk stratification by exercise testing  
25. Doppler echocardiography (surgical timing)  
26. Multidetector CT angiography (imaging of aortic stenosis)  
27. Cardiac outcomes (adult survivors of supravalvar aortic stenosis)  
28. Surgical repair (coronary ostial stenosis, supravalvar aortic stenosis)  
29. Decision aids for prosthetic valve selection  
30. Family screening for bicuspid aortic valve and aortic aneurysm  
31. Aortic valve pathology (diffuse variant, elastin deficiency)  
32. Aortic valve molecular genetics  
33. Decision‑making in valvular heart disease (shared decision‑making)  
34. Pediatric subvalvular aortic stenosis risk factors  
35. Adult congenital aortic valve interventions  
36. Aortic valve replacement outcomes in congenital versus native valve disease  
37. Aortic stenosis in heterozygous/homozygous familial hypercholesterolemia  
38. Aortic valve complications (e.g., restenosis, prosthetic valve dysfunction)  
39. Aortic valve hemodynamics (flow velocity, gradient)  
40. Aortic valve surgical indications and timing  

These terms capture the key clinical entities, procedural approaches, imaging modalities, risk factors, and guideline‑specific concepts related to heart disease in the provided citations.

Page 119 Extracted Terms:
- Williams syndrome  
- Williams‑Beuren syndrome  
- Congenital heart disease  
- Supravalvular aortic stenosis  
- Coarctation of the aorta  
- Aortic coarctation (native and repaired)  
- Left ventricular ejection fraction  
- Left ventricular hypertrophy  
- Left ventricle strain imaging  
- Coronary artery stenosis  
- Coronary artery disease  
- Myocardial ischemia  
- Pulmonary hypertension  
- Exercise‑induced hypertension  
- Ambulatory blood pressure monitoring  
- Endothelial dysfunction  
- Conduit artery dysfunction  
- Left atrial dysfunction  
- Right heart dysfunction  
- Intraventricular myocardial stiffness  
- Cardiac remodeling  
- Cardiovascular mortality  
- Cardiac surgery (repair, stenting, transcatheter intervention)  
- Systolic blood pressure control  
- Hypertension management (restenosis‑free)  
- Intracranial aneurysms screening  
- Clinical risk stratification in congenital heart disease  
- Prevention of sudden death in Williams‑Beuren syndrome  
- Left ventricular mass and geometry assessment  
- Prognostic impact of LV function in aortic stenosis  
- Screening for intracranial aneurysms in coarctation of the aorta  
- Pediatric and adult outcomes after coarctation repair  
- Percutaneous intervention outcomes for coarctation  
- Diagnostic imaging for coronary and cerebral circulation in coarctation  
- Heart failure with preserved ejection fraction (HFpEF) in coarctation patients  

Page 120 Extracted Terms:
- Coarctation of the aorta  
- Endovascular treatment  
- Stent trials  
- Transcatheter interventions  
- Left ventricular reverse remodeling  
- Left ventricular remodeling  
- Cardiovascular burden  
- Congenital heart disease (CHD)  
- Ebstein’s anomaly  
- Accessory pathway ablation  
- Wolff‑Parkinson‑White syndrome  
- Echocardiography  
- Cardiac magnetic resonance imaging (CMR)  
- Cone operation (cone reconstruction)  
- Biventricular function  
- Catheter ablation of ventricular arrhythmia  
- Electrophysiologic studies (EPS)  
- Tricuspid valve imaging  
- Right ventricular unloading  
- Bi‑directional cavo‑pulmonary shunt  
- Surgical intervention timing  
- Hemodynamic determinants of aerobic capacity  
- Supraventricular arrhythmias  
- Percutaneous atrial septal defect (ASD) closure  
- Mortality in Ebstein’s anomaly  
- Occult left ventricular dysfunction  
- Atrial fibrillation (AF)  
- Arrhythmia management in adult CHD  
- Cardiopulmonary exercise testing  
- Pulmonary stenosis  
- Percutaneous balloon valvuloplasty (balloon pulmonary valvuloplasty)  
- Pulmonary valve replacement (PVR)  
- Pulmonary regurgitation  
- Tricuspid valve intervention  
- Birth prevalence of congenital heart defects  
- Semilunar valve interventions  
- Long‑term outcomes (up to 25–40 years)  
- Exercise capacity  
- Ventricular volume and function  
- Aortic coarctation gradients  
- Left ventricular function  
- Aortic stenosis (implicitly via aortic coarctation)  
- Ventricular tachycardia (VT)  
- Ventricular arrhythmia  
- Aortic balloon valvuloplasty  
- Cardiovascular magnetic resonance (CMR) imaging terms (e.g., dyssynchrony, remodeling, cone reconstruction feasibility)  
- Heart failure related to Ebstein malformation  
- Right ventricular function  

(Note: The list compiles key heart‑disease concepts, conditions, interventions, and clinical outcomes presented in the provided text.)

Page 121 Extracted Terms:
- Pulmonary valve replacement  
- Transcatheter pulmonary valve replacement  
- Tricuspid regurgitation  
- Right ventricular volume/pressure overload  
- Pulmonary valve stenosis  
- Repaired tetralogy of Fallot  
- Pulmonary regurgitation  
- Right‑ventricular (RV) remodeling  
- Right‑ventricular outflow tract (RVOT)  
- Ventricular septal defect (VSD)  
- Double‑chambered right ventricle (DCRV)  
- Branch pulmonary artery stenosis  
- Balloon angioplasty  
- Stenting  
- Cardiac magnetic resonance imaging (CMR)  
- Multimodality imaging (echocardiography, CMR, CT, scintigraphy)  
- SAPIEN S3 transcatheter heart valve  
- 2018 AHA/ACC guideline for adults with congenital heart disease  
- Appropriate use criteria for multimodality imaging in congenital heart disease  
- Congenital heart disease (CHD)  
- Pulmonary valve dysfunction  
- Right‑ventricular ejection fraction (RVEF)  
- Right‑ventricular strain and deformation  
- Hemodynamically significant pulmonary regurgitation  
- Pressure half‑time (PHT)  
- Exertional performance / exercise capacity  
- Imaging assessment of pulmonary stenosis and regurgitation  
- Surgical outcomes and repair of DCRV  
- Post‑operative outcomes of pulmonary valve replacement  
- Long‑term natural history of pulmonary stenosis after surgical repair  
- Clinical practice guidelines for management of pulmonary valve disease  
- Complications of pulmonary artery interventions (adverse events, procedural characteristics)

Page 122 Extracted Terms:
Tetralogy of Fallot  
Pulmonary valve replacement (PVR)  
Pulmonary valve implantation  
Ventri­cular tachycardia (VT)  
Implantable cardioverter‑defibrillator (ICD)  
Arrhythmogenic substrate  
Right ventricular outflow tract (RVOT)  
Conduit  
Bioprosthetic valve  
Pulmonary artery stenosis (PAS)  
Peripheral pulmonary artery stenosis  
Transcatheter pulmonary valve implantation  
Transcatheter pulmonary valve replacement  
Pulmonary regurgitation  
Right ventricular dysfunction  
Right ventricular volume overload  
Tricuspid regurgitation  
Right ventricular activation  
Left ventricular diastolic function  
Left ventricular systolic dysfunction  
Left ventricular longitudinal strain  
QRS fragmentation  
QRS duration  
Cardiac magnetic resonance (CMR)  
Multidetector computed tomography (MDCT)  
Computed tomography angiography (CTA)  
Electrocardiogram (ECG)  
Electroanatomical mapping  
Ventricular arrhythmia  
Sudden cardiac death  
Arrhythmic risk stratification  
Ventricular tachycardia isthmus  
Electrophysiologic study  
Ablation therapy  
Ventricular tachycardia substrate  
Ventricular tachycardia‑related anatomical isthmuses  
Ventricular tachycardia substrate characteristics  
Ventricular tachycardia risk  
Ventricular arrhythmia burden  
Post‑operative survival  
Long‑term outcomes  
Pulmonary valve dysfunction  
Pulmonary valve stenosis  
Right ventricular remodeling  
Cardiac conduction system  
Cardiac arrhythmia  
Right ventricular size  
Right ventricular function  
Congenital heart disease (CHD)  
Adult congenital heart disease (ACHD)  
AHA/ACC clinical practice guideline  
ACHD guideline

Page 123 Extracted Terms:
- Tetralogy of Fallot  
- Repaired tetralogy of Fallot  
- Pulmonary valve replacement  
- Pulmonary regurgitation  
- Pulmonary valve insufficiency  
- Right ventricular dilation  
- Right ventricular systolic function  
- Right ventricular free‑wall strain  
- Right ventricular volume / left ventricular volume ratio  
- Biventricular interaction  
- Biventricular global‑function index  
- Ventricular tachycardia  
- Ventricular arrhythmia  
- Ventricular fibrosis  
- Fragmented QRS complex  
- QRS duration  
- Slow‑conducting electroanatomic isthmus  
- Late gadolinium enhancement  
- Cardiac magnetic resonance (CMR)  
- Cardiac MRI  
- Echocardiography  
- Speckle‑tracking echocardiography  
- Multimodality imaging  
- Cardiac computed tomography (CT) angiography  
- Cardiopulmonary exercise testing  
- Non‑sustained ventricular tachycardia  
- Implantable cardioverter‑defibrillator (ICD)  
- ICD shocks (inappropriate)  
- Sudden cardiac death  
- Mortality risk score  
- Cardiac risk score  
- Right atrial area  
- Right ventricular outflow‑tract dysfunction / akinetic length  
- Electroanatomic mapping  
- Catheter ablation of ventricular tachycardia  
- Surgical ablation of ventricular tachycardia  
- Ventricular tachycardia inducibility  
- ECG algorithm (R'' wave in V1 & terminal QRS vector in aVF)  
- Clinical practice guidelines  
- Adult congenital heart disease (ACHD)  
- Congenital heart disease (CHD)  
- Pulmonary valve replacement timing  
- Preoperative predictors of death  
- Post‑operative outcomes  
- Ventricular tachycardia substrate characterization  
- Pulmonary valve regurgitation quantification  
- Cardiac output  
- Left ventricular ejection fraction  
- Cost of treating ICD patients  
- Quality of life in ICD patients  
- Psychological functioning in ICD patients

Page 124 Extracted Terms:
Tetralogy of Fallot  
Pulmonary valve replacement  
Right ventricular volume  
Right ventricular function  
Pulmonary regurgitation  
Left ventricular cardiomyopathy  
Tricuspid regurgitation  
Tricuspid repair  
Right ventricular outflow tract (RVOT)  
Conduit  
Monomorphic ventricular tachycardia  
Ventricular tachycardia  
Adult congenital heart disease  
Pulmonary atresia  
Intact ventricular septum  
Biventricular repair  
Right ventricular fibrosis  
Single‑ventricle palliation  
Fontan procedure  
Late myocardial ischemia  
Systemic venous hypertension  
Low output  
Right atrial dysfunction  
Transcatheter pulmonary valve implantation (Melody valve)  
Endocarditis  
Infective endocarditis  
Bioprosthetic valve  
Bioprosthetic valve thrombosis  
Echocardiography  
Cardiac magnetic resonance imaging  
Computed tomography angiography  
Coronary artery compression  
Stent fracture  
Valve dysfunction  
RVOT obstruction  
Pressure gradient  
RVOT reintervention  
Congenital heart defect  
Right ventricular remodeling  
Right ventricular loading  
Aortic‑pulmonary transposition  
Systemic right ventricle  
Endovascular stenting  
Catheterization  
Functional outcome  
Long‑term outcomes  
Acute outcomes  
Midterm outcomes

Page 125 Extracted Terms:
- Adult congenital heart disease  
- Transposition of the great arteries (dextro‑TGA)  
- Atrial switch operation (Mustard, Senning)  
- Systemic right ventricle  
- Pulmonary valve dysfunction  
- Transcatheter pulmonary valve replacement  
- SAPIEN 3 transcatheter heart valve  
- Balloon‑expandable valve  
- Baffle leak / baffle obstruction  
- Ventricular arrhythmias  
- Sudden cardiac death  
- Mechanical circulatory support (bridge to transplant, LVAD)  
- Heart failure with systemic right ventricular failure  
- Cardiac resynchronization therapy  
- Anticoagulation (NOACs) for systemic right ventricle  
- Dapagliflozin therapy (heart failure)  
- Sacubitril/valsartan therapy (heart failure)  
- Myocardial work analysis (biventricular performance)  
- Risk scoring for major clinical events (post‑atrial switch)  
- Ventricular arrhythmia risk score  
- Cardiac MRI predictors of adverse outcomes  
- Ventricular size and function (subpulmonary left ventricle)  
- Cardiopulmonary exercise testing (ventilatory efficiency, aerobic capacity)  
- Cyanosis‑associated exercise response  
- Magnetic navigation & robotic ablation (atrial tachyarrhythmias)  
- Stent placement (intra‑vascular, baffle)  
- Catheter‑based interventions for baffle repair  
- Exercise capacity guidelines for congenital heart disease athletes  
- Competitive sport participation recommendations (CHD)  
- Multimodality imaging guidelines (echocardiography, CMR, CT)  
- Machine‑learning assessment of systemic right ventricle  
- Non‑invasive respiratory monitoring for congenital heart disease.

Page 126 Extracted Terms:
- Congenital heart disease  
- Transposition of the great arteries  
- Arterial switch operation  
- Atrial switch operation (Senning/Mustard)  
- Systemic right ventricle  
- Transcatheter pacing leads  
- Implantable cardioverter‑defibrillator (ICD)  
- Implantable loop recorder  
- Late gadolinium enhancement cardiovascular magnetic resonance  
- Pulmonary stenosis  
- Neo‑aortic regurgitation  
- Neo‑aortic root growth  
- Aortic root dilatation  
- Aortic valve regurgitation  
- Coronary artery complications  
- Coro​nary events  
- Coro​nary artery bypass grafting (bypass)  
- Mechanical circulatory support (LVAD, VAD)  
- Heart failure (advanced)  
- Thromboprophylaxis for atrial arrhythmias  
- Tricuspid valve replacement  
- Tricuspid valve repair  
- Cardiac resynchronization therapy  
- Angiotensin receptor blockers (e.g., valsartan, losartan)  
- Phosphodiesterase‑5 inhibitors (e.g., sildenafil)  
- Sacubitril‑valsartan (ARNI)  
- Exercise capacity reduction  
- Arrhythmia detection  
- Coronary artery compression  
- Coronary artery graft failure  
- Pulmonary artery evaluation  
- Four‑dimensional flow magnetic resonance imaging  
- Myocardial stress perfusion MRI (regadenoson)  
- Echocardiography (transthoracic, transesophageal)  
- Afterload reduction therapy  
- Ventricular deformation imaging  
- Medical therapy for systemic right ventricle  
- Cardiac transplant outcomes  
- Cardiac transplant bridge (mechanical assist device)  
- Transplantation referral for thoracic organ disease  
- Renal dysfunction in advanced heart failure  
- Patient‑reported health status  
- Long‑term survival after arterial switch  
- Long‑term survival after atrial switch / arterial switch  
- Cardiac surgical outcomes in d‑transposition of the great arteries  
- Neonatal and pediatric outcomes after arterial switch  
- Late coronary artery complications post‑arterial switch  
- Pulmonary artery stenosis after arterial switch  
- Long‑term prognosis of neo‑aortic root  
- Coronary artery anatomy post‑arterial switch  
- Left ventricular assist device support in transposition of the great arteries  
- Mechanical ventricular assist device  
- Cardiac surgery for d‑transposition of the great arteries.

Page 127 Extracted Terms:
- D‑transposition of the great arteries (D‑TGA)  
- Transposition of the great arteries (TGA)  
- Arterial switch operation (Jatene procedure)  
- Rastelli repair  
- Nikaidoh procedure  
- Reverse‑edge ventricular outflow tract (REV) procedure  
- Double‑outlet right ventricle (DORV)  
- Ventricular septal defect (VSD)  
- Pulmonary valve stenosis (PVS)  
- Pulmonary arteriovenous malformation  
- Pulmonary artery stenosis (PAS)  
- Branch pulmonary artery stenosis  
- Right ventricular dysfunction / failure  
- Left ventricular outflow tract obstruction (LVOTO)  
- Pulmonary outflow tract obstruction (POTO)  
- Biventricular outflow tract reconstruction  
- Aortic translocation  
- Aortic valve–sparing root replacement  
- Bentall procedure  
- Congenital heart disease (CHD)  
- Complex congenital heart disease  
- Chronic coronary disease / coronary artery disease (CAD)  
- Aortic disease (including aortic dissection and aneurysm)  
- Infective endocarditis (post‑valve or post‑repair)  
- Transcatheter pulmonary valve replacement  
- Melody valve  
- Branch pulmonary artery reintervention  
- Pulmonary artery gradient  
- Coronary artery anatomy (specifically coronary pattern post‑arterial switch)  
- Residual coronary/arterial gradients  
- Right ventricular to pulmonary arterial coupling  
- Biventricular surgical strategy  
- Coronary artery reintervention  
- Exercise capacity metrics (e.g., VO₂ max)  
- Multimodality imaging guidelines (Echocardiography, MRI, CT)  
- 4‑D flow MRI  
- 3‑D magnetic resonance imaging of coronary arteries  
- Echocardiography  
- Cardiothoracic magnetic resonance imaging (CMR)  
- Cardiac computed tomography (CCT)  
- Congenital heart disease management guidelines (ACC/AHA, AHA/ACC, etc.)  
- 2020 ACC/AHA guideline for valvular heart disease  
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for chronic coronary disease  
- 2022 ACC/AHA guideline for aortic disease  
- 2019 AHA/ACC guideline for adults with congenital heart disease  
- 2018 AHA/ACC guideline for management of adults with congenital heart disease (Task Force)  
- 2025 ACHD guideline  
- Outcomes studies of arterial switch operation  
- Outcomes studies of Rastelli repair  
- Outcomes studies of Nikaidoh/REV procedures  
- Outcomes studies of double‑root translocation  
- Outcomes studies of pulmonary‑to‑pulmonary conduits  
- Outcomes studies of biventricular right‑ventricle–pulmonary‑artery conduits  
- Neurocognitive and psychological outcomes in adults with corrected D‑TGA  
- Quality‑of‑life outcomes after neonatal arterial switch operation  
- Long‑term myocardial infarction outcomes in adults with congenital heart disease  
- Age‑ and lesion‑related comorbidity burden in congenital heart disease  
- Long‑term survival and freedom from coronary artery reintervention post‑arrest  
- Impact of coronary artery anatomy on surgical outcomes  
- Imaging assessment of neopulmonary outflow tract obstruction  
- Coronary artery obstruction surveillance post‑arterial switch  
- Pulmonary valve replacement risks and complications  
- Surgical repair of pulmonary valve atresia with coronary‑pulmonary artery fistula  
- Surgical repair of transposition with VSD and subpulmonary stenosis  
- Surgical repair strategies for complex transposition (double‑root, Rastelli, Nikaidoh, REV, etc.)  
- Arrhythmias in adults after Rastelli surgery  
- Long‑term follow‑up of patients undergoing pulmonary‑ventricle to pulmonary artery conduits  
- Surgical outcomes of double‑root translocation for TGA with pulmonary stenosis  

(These are the primary terms extracted from the provided clinical statements and guidelines that relate to heart disease.)

Page 128 Extracted Terms:
- Congenital heart disease (CHD)  
- Congenitally corrected transposition of the great arteries (CCTGA)  
- Systemic right ventricle (SRV)  
- Truncus arteriosus  
- Double‑outlet right ventricle (DORV)  
- Fontan palliation / Fontan circulation  
- Single ventricle (functional single‑ventricle heart)  
- Atrioventricular valve surgery (e.g., systemic AV valve repair)  
- Tricuspid valve replacement / tricuspid regurgitation  
- Systemic ventricular dysfunction / SRV failure  
- Arrhythmia (atrial & ventricular)  
- Arrhythmia burden, atrial arrhythmia, atrial switch operation  
- Cardiac resynchronization therapy (CRT)  
- Cardiac remodeling  
- Echocardiography (including 3‑D, transesophageal, and imaging for ventricular strain)  
- Longitudinal strain of the systemic right ventricle  
- Exercise capacity / aerobic capacity / exercise tolerance  
- Cardiac output augmentation  
- Angiotensin‑receptor neprilysin inhibitor (ARNI) therapy  
- Sacubitril/valsartan use in systemic RV failure  
- Thrombotic/embolic complications (atrial thrombosis, emboli)  
- Thromboprophylaxis (including direct oral anticoagulants)  
- Pacemaker implantation / ventricular pacing effects  
- Mortality / morbidity in adult Fontan patients  
- Hepatocellular carcinoma & liver cirrhosis (in Fontan patients)  
- Pulmonary valve and aortic root translocation / en‑bloc rotation procedures  
- Virtual surgical planning / 3‑D modelling of intracardiac baffles (DORV)  
- Exercise training / resistance training in Fontan and single‑ventricle patients  
- Post‑operative outcomes for repair of truncus arteriosus, DORV, and Fontan surgeries  
- Chromosome 22q11 deletion in truncus arteriosus patients.

Page 129 Extracted Terms:
Fontan operation  
Fontan circulation  
Fontan physiology  
Fontan failure  
Fontan-associated complications  
Fontan-associated liver disease  
Fontan-associated thrombosis  
Fontan thrombus  
Fontan conversion surgery  
Fontan procedure  
Fontan patient  
Fontan surgery outcomes  
Single ventricle physiology  
Ventricular physiology after Fontan  
Supraventricular tachyarrhythmia  
Atrial arrhythmia  
Atrial tachyarrhythmia  
Supraventricular tachycardia  
Atrial flutter  
Atrial fibrillation  
Cardiac arrhythmias  
Arrhythmias post‑Fontan  
Thromboembolism  
Thromboembolic complications  
Thrombosis  
Thrombus formation  
Intracardiac thrombus  
Intracardiac thrombi  
Anticoagulant therapy  
Antiplatelet therapy  
Warfarin  
Aspirin  
Non‑vitamin K antagonist oral anticoagulants  
Thromboprophylaxis  
Antithrombotic regimens  
Anticoagulation  
Hemodynamic monitoring  
Hemodynamics  
Cardiac pacing  
Ventricular pacing  
Atrial pacing  
Pacemaker lead  
Pacing complications  
Heart transplant  
Advanced heart failure  
Heart failure consultation  
Liver fibrosis  
Transjugular liver biopsy  
Magnetic resonance elastography  
Peak oxygen consumption  
Exercise capacity  
Iron deficiency  
Creatinine  
Cystatin C  
Glomerular filtration rate  
Thrombotic complications  
Portal hypertension  
Hepatocellular carcinoma  
Liver cancer  
Liver nodules  
Liver disease  
Aortopulmonary shunt  
Cavopulmonary shunt  
Extracardiac conduit  
Intracardiac conduit  
Azygous continuation of inferior vena cava  
Computed tomography angiography  
CT angiography  
Echocardiography  
Transesophageal echocardiography  
Transthoracic echocardiography  
Magnetic resonance imaging  
Cardiothoracic imaging  
Cardiac MRI  
Cardiac CT  
Clinical phenotypes  
Clinical outcomes  
Survival  
Mortality  
Late mortality  
Predictors of mortality  
Outcomes of pacing  
Cardiac complications  
Late death  
Late complications  
Early thrombosis  
Thromboembolic events  
Thrombotic events  
Hemodynamic study

Page 130 Extracted Terms:
- Fontan physiology  
- Fontan circulation  
- Fontan procedure  
- Fontan conversion  
- Fontan pathway  
- Fontan conduit stent‑angioplasty  
- Single‑ventricle physiology  
- Atrioventricular valve failure  
- Atrioventricular valve replacement  
- Heart‑liver transplantation  
- Dual‑site ventricular pacing  
- Heart block  
- Atrial arrhythmias  
- Late atrial tachycardia  
- Cryoablation  
- Pacemaker therapy  
- Arrhythmia surgery  
- Extracardiac Fontan conversion  
- Amiodarone therapy  
- Ambrisentan therapy  
- Sildenafil therapy  
- Pulmonary arterial hypertension (PAH)  
- Pulmonary hypertension in congenital heart disease  
- Eisenmenger syndrome  
- Bosentan therapy  
- Tadalafil therapy  
- Phosphodiesterase‑5 inhibitors  
- Pulmonary vasodilators  
- Pulmonary vascular resistance  
- Aortopulmonary collaterals  
- Systemic‑to‑pulmonary arterial collaterals  
- Superior caval‑pulmonary connections  
- Aortopulmonary shunt closure  
- Congenital heart disease (CHD) – adult population  
- Shunt closure complications  
- Hypoplastic left heart syndrome (HLHS) – Norwood repair  
- Early developmental outcome in single‑ventricle reconstruction  
- Pregnancy outcomes in Eisenmenger syndrome  
- Maternal outcomes in congenital heart disease‑associated pulmonary hypertension  
- Exercise tolerance in Fontan patients  
- Central venous pressure prediction  
- Stenosis of Fontan connection  
- Stroke prevention in atrial arrhythmias  
- Hemodynamics of Fontan failure  
- Exercise capacity after heart transplantation  
- Long‑term survival after Fontan procedure  
- Peri‑operative morbidity in Fontan surgery  
- Surgical conversion strategies for Fontan patients  
- Outcome of atrioventricular valve surgery post‑Fontan  
- Outcomes of atrial tachycardia ablation in Fontan patients  
- Long‑term outcome after atrioventricular valve surgery following modified Fontan operation  
- Atrial fibrillation and atrial flutter in congenital heart disease  
- Heart transplantation for complex congenital heart disease  
- Fontan‑associated liver disease  
- Stent placement in Fontan pathway  
- Pulmonary vasodilatory therapy efficacy  
- Pulmonary arterial hypertension guidelines for adults  
- CHEST guideline on pulmonary arterial hypertension  
- AHA/ACC guideline for adults with congenital heart disease  
- Cardiac rehabilitation in congenital heart disease  
- Arrhythmia management in adult congenital heart disease  

These terms capture the key heart‑disease concepts, interventions, and related conditions addressed in the guideline excerpts.

Page 131 Extracted Terms:
Eisenmenger syndrome  
Pulmonary arterial hypertension  
Congenital heart disease  
Eisenmenger physiology  
Pulmonary hypertension  
Right ventricular function  
Left ventricular function  
Biventricular dysfunction  
Ventricular septal defect  
Arrhythmias  
Atrial fibrillation  
Anticoagulation therapy  
Thromboprophylaxis  
Prostacyclin therapy  
Bosentan  
Sildenafil  
Ambrisentan  
Iloprost  
Riociguat  
Triple vasodilator therapy  
Leadless pacemaker implantation  
Leadless atrioventricular synchronous pacing  
Exercise training  
Exercise limitations  
Physical functioning  
Quality of life  
Oxygen saturation  
Pulmonary vascular resistance  
Pulmonary arterial thrombosis  
B‑type natriuretic peptide  
Cardiopulmonary magnetic resonance  
Thromboembolic events  
Cardiovascular complications in pregnancy  
Tachyarrhythmia management  
Transvenous pacing leads  
Surgical correction of left‑to‑right shunts  
Anomalous aortic origin of a coronary artery  
Anomalous coronary artery  
MRI angiography (non‑contrast, free‑breathing)  
Coronary CTA (computed tomography angiography)

Page 132 Extracted Terms:
- Anomalous coronary artery  
- Anomalous coronary artery origin  
- Anomalous aortic origin of the coronary artery  
- Anomalous right coronary artery from the left sinus of Valsalva  
- Anomalous left coronary artery from the pulmonary artery  
- Coronary artery reimplantation (correction of anomalous origin)  
- Coronary artery fistula  
- Vascular ring  
- Pulmonary artery sling  
- Congenital heart disease (adult)  
- Sudden cardiac death (associated with coronary anomalies)  
- Ischemia (identified by myocardial perfusion imaging)  
- Coronary artery disease (obstructive disease in congenital anomalies)  
- Fractional flow reserve (assessment of haemodynamic significance)  
- Stress cardiac magnetic resonance imaging (dobutamine or other)  
- Positron emission tomography myocardial perfusion imaging  
- Coronary angiography (used to evaluate anomalies)  
- Transcatheter fistula closure (management of coronary artery fistula)  
- Surgical correction of anomalous coronary artery origins.

Page 133 Extracted Terms:
- Adults With Congenital Heart Disease  
- Congenital Heart Disease  
- Adult Congenital Heart Disease Fellowship  
- Adult Congenital Heart Program  
- Congenital Cardiothoracic Surgery  
- Cardiovascular Medicine  
- Cardiology

Page 134 Extracted Terms:
**Key heart‑disease related terms extracted from the text**

- Adult Congenital Heart Disease  
- Congenital Heart Disease  
- Cardiology  
- Pediatric Cardiology  
- Cardiovascular Medicine  
- Heart Transplantation  
- Advanced Congenital Cardiac Therapies  
- Adult Single Ventricle Clinic  
- Heart Institute  
- Heart Center  
- Cardiac Therapies  
- Electrophysiology  
- Heart Failure  
- ISACHD (International Society for Adult Congenital Heart Disease)  
- ACHD (Adult Congenital Heart Disease)  
- Heart Disease  
- Heart Transplant  
- Heart Institute (dual reference)

Page 135 Extracted Terms:
- Adult Congenital Heart Disease  
- Congenital Heart Disease  
- Cardiovascular Disease  
- Aortic Valve Replacement  
- Transcatheter Aortic Valve Replacement  
- Cardiology  
- Cardiac  
- Myocardial Infarction  
- Heart Disease  
- Heart Rhythm  
- Pregnancy and Cardiovascular Disease Program  
- Adult Congenital Cardiac Clinic  
- American Heart Association (AHA)  
- American College of Cardiology (ACC)  
- International Society for Adult Congenital Heart Disease (ISACHD)  
- Heart Rhythm Society (HRS)  
- Society for Cardiovascular Angiography and Intervention (SCAI)  
- National Heart, Lung, and Blood Institute (NHLBI)  
- National Institutes of Health (NIH)

Page 136 Extracted Terms:
**Key terms related to heart disease extracted from the text**

- Adult Congenital Heart Disease (ACHD)  
- Congenital Heart Disease  
- Congenital cardiac conditions  
- Congenital heart surgery  
- Adult congenital heart disease management  
- Cardiology  
- Cardiology practice  
- Cardiologist  
- Pediatric cardiology / Paediatric cardiology  
- Congenital heart surgeon  
- ACHD Program  
- Adult Congenital Heart Association (ACHA)  
- American Heart Association (AHA)  
- American College of Cardiology (ACC)  
- Heart Rhythm Society (HRS)  
- International Society for the Advancement of Cardiovascular Surgery (ISACHD)  
- Society for Cardiovascular Angiography and Interventions (SCAI)  
- Clinical guideline for ACHD  
- Guideline peer‑review committee  
- Interventional cardiac systems  
- Cardiovascular devices  
- Life‑sciences technology  
- Medical devices for heart disease  
- Cardiac clinical education / training  
- Cardiac surgery education  

These terms capture the primary heart‑disease concepts and specialties referenced in the guideline text.

Page 137 Extracted Terms:
Adult Congenital Heart Disease (ACHD)  
Congenital Heart Disease (CHD)  
Fontan Procedure / Fontan Outcomes Network  
International Society for Adult Congenital Heart Disease (ISACHD)  
American Heart Association (AHA)  
American College of Cardiology (ACC)  
Adult Congenital Heart Association (ACHA)  
Alliance for Adult Research in Congenital Cardiology (AARCC)  
Heart Rhythm Society (HRS)  
National Heart, Lung, and Blood Institute (NHLBI)  
Society for Cardiovascular Angiography & Interventions (SCAI)  
Cardiologist  
Interventional Cardiologist  
Cardiovascular Medicine  
Pediatric Cardiology  
Medtronic (cardiovascular devices)  
Abbott Laboratories  
B Braun Medical  
Biosense Webster  
Occlutech  
Edward Life‑sciences  
Quidel (diagnostics)

